+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 55912

Chapter 55912 provides scholary research titles of which PDF Full Texts are available through EurekaMag.





Orth, P.; Anagnostakos, K.; Fritsch, E.; Kohn, D.; Madry, H., 2012:
Static winging of the scapula caused by osteochondroma in adults: a case series

Calderín, L.; González, L.E.; González, D.J., 2011:
Static, dynamic and electronic properties of expanded fluid mercury in the metal-nonmetal transition range. An ab initio study

Liu, J.; Zhang, L.; Cao, D.; Wang, W., 2009:
Static, rheological and mechanical properties of polymer nanocomposites studied by computer modeling and simulation

Sueoka, S.Sato.; Detemple, K., 2011:
Static-progressive splinting in under 25 minutes and 25 dollars

Csonka, P.L., 1983:
Static-wavelength independent radiation attenuator

Pertsinidis, A.; Ling, X.Sean., 2008:
Statics and dynamics of 2D colloidal crystals in a random pinning potential

Reichhardt, C.; Olson Reichhardt, C.J., 2012:
Statics and dynamics of Yukawa cluster crystals on ordered substrates

Servantie, J.; Müller, M., 2008:
Statics and dynamics of a cylindrical droplet under an external body force

Besson, S.; Debrégeas, G., 2007:
Statics and dynamics of adhesion between two soap bubbles

Zausch, J.; Virnau, P.; Binder, K.; Horbach, Jürgen.; Vink, R.L., 2009:
Statics and dynamics of colloid-polymer mixtures near their critical point of phase separation: A computer simulation study of a continuous Asakura-Oosawa model

Lee, A.A.; Colby, R.H.; Kornyshev, A.A., 2013:
Statics and dynamics of electroactuation with single-charge-carrier ionomers

Vila Verde, A.; Bolhuis, P.G.; Campen, R.Kramer., 2012:
Statics and dynamics of free and hydrogen-bonded OH groups at the air/water interface

Schmidt, M., 2011:
Statics and dynamics of inhomogeneous liquids via the internal-energy functional

Brasselet, E.; Murazawa, N.; Juodkazis, S.; Misawa, H., 2008:
Statics and dynamics of radial nematic liquid-crystal droplets manipulated by laser tweezers

Heussinger, C.; Schüller, F.; Frey, E., 2010:
Statics and dynamics of the wormlike bundle model

Vella, D.; Boudaoud, A.; Adda-Bedia, M., 2009:
Statics and inertial dynamics of a ruck in a rug

Léonforte, F.; Müller, M., 2011:
Statics of polymer droplets on deformable surfaces

Yaoita, T.; Isaki, T.; Masubuchi, Y.; Watanabe, H.; Ianniruberto, G.; Greco, F.; Marrucci, G., 2008:
Statics, linear, and nonlinear dynamics of entangled polystyrene melts simulated through the primitive chain network model

Bause, G.S., 2013:
Statikil sparked Paul Wood's interest

Cao, Z.; Zhou, B.; Chen, X.; Huang, D.; Zhang, X.; Wang, Z.; Huang, H.; Wang, Y.; Cao, D., 2015:
Statil suppresses cancer cell growth and proliferation by the inhibition of tumor marker AKR1B10

Chaudhry, M.Z.; Wang, J.Huai.; Blankson, S.; Redmond, H.Paul., 2008:
Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance

Moyad, M.A.; Klotz, L.H., 2011:
Statin Clinical Trial (REALITY) for prostate cancer: an over 15-year wait is finally over thanks to a dietary supplement

Lee, S-Hwan.; Kwon, H-Sang.; Park, Y-Moon.; Ko, S-Hyun.; Choi, Y-Hee.; Yoon, K-Ho.; Ahn, Y-Bae., 2014:
Statin Discontinuation after Achieving a Target Low Density Lipoprotein Cholesterol Level in Type 2 Diabetic Patients without Cardiovascular Disease: A Randomized Controlled Study

Sikka, P.; Saxena, K.K.; Kapoor, S., 2012:
Statin Hepatotoxicity: Is it a Real Concern?

Jameel, A.; Ooi, K.G-J.; Jeffs, N.R.; Galatowicz, G.; Lightman, S.L.; Calder, V.L., 2013:
Statin Modulation of Human T-Cell Proliferation, IL-1β and IL-17 Production, and IFN-γ T Cell Expression: Synergy with Conventional Immunosuppressive Agents

Hong, K-Sik.; Oh, M.Sun.; Choi, H-Yeon.; Cho, A-Hyun.; Kwon, H-Min.; Yu, K-Ho.; Bae, H-Joon.; Lee, J.; Lee, B-Chul., 2013:
Statin Prescription Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack

Hung, C-Ying.; Hsieh, Y-Cheng.; Huang, J-Long.; Lin, C-Heng.; Wu, T-Juey., 2014:
Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score

Sethi, A.; Bajaj, A.; Khosla, S.; Arora, R.R., 2014:
Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation-A Meta-Regression of Randomized Trials

Veronese, G.; Montomoli, J.; Schmidt, M.; Horváth-Puhó, Eébet.; Sørensen, H.Toft., 2016:
Statin Use and Risk of Atrial Fibrillation or Flutter: A Population-based Case-Control Study

Singh, S.; Singh, P.Paul., 2013:
Statin a day keeps cancer at bay

McGinnis, B.D.; Olson, K.L.; Delate, T.M.A.; Stolcpart, R.S., 2010:
Statin adherence and mortality in patients enrolled in a secondary prevention program

Dormuth, C.R.; Patrick, A.R.; Shrank, W.H.; Wright, J.M.; Glynn, R.J.; Sutherland, J.; Brookhart, M.Alan., 2009:
Statin adherence and risk of accidents: a cautionary tale

Ruokoniemi, Päivi.; Korhonen, M.J.; Helin-Salmivaara, A.; Lavikainen, P.; Jula, A.; Junnila, S.Y.T.; Kettunen, R.; Huupponen, R., 2011:
Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study

Merzon, E.; Weiss, N.S.; Lustman, A.James.; Elhayani, A.; Dresner, J.; Vinker, S., 2010:
Statin administration and risk of cholecystectomy: a population-based case-control study

Kor, D.J.; Iscimen, R.; Yilmaz, M.; Brown, M.J.; Brown, D.R.; Gajic, O., 2009:
Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury

Wang, H.; Yang, Y-J.; Qian, H-Y.; Zhang, Q.; Gao, L-J.; Li, P.; Wang, T-J.; Wang, S-D., 2013:
Statin administration does not improve the mobilization of very small embryonic-like stem cells (VSELs) in contrast to resveratrol treatment in a murine model of acute myocardial infarction

Golomb, B.A.; Evans, M.A., 2009:
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

Mlodinow, S.G.; Onysko, M.K.; Vandiver, J.W.; Hunter, M.L.; Mahvan, T.D., 2015:
Statin adverse effects: sorting out the evidence

Olsson, A.G., 2011:
Statin after intracerebral hemorrhage should be questioned. Subgroup analyses show increased risk of new hemorrhage

Satoh, K.; Fukumoto, Y.; Nakano, M.; Sugimura, K.; Nawata, J.; Demachi, J.; Karibe, A.; Kagaya, Y.; Ishii, N.; Sugamura, K.; Shimokawa, H., 2009:
Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1

Coogan, P.F.; Kelly, J.Parsells.; Strom, B.L.; Rosenberg, L., 2010:
Statin and NSAID use and prostate cancer risk

Anonymous, 2007:
Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value

Carrat, F., 2014:
Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?

Udell, J.A.; Scirica, B.M.; Braunwald, E.; Raz, I.; Steg, P.Gabriel.; Davidson, J.; Hirshberg, B.; Bhatt, D.L., 2013:
Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus

Chae, Y.Kwang.; Trinh, L.; Jain, P.; Wang, X.; Rozovski, U.; Wierda, W.G.; Keating, M.J.; Estrov, Z., 2014:
Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia

Leoncini, M.; Toso, A.; Maioli, M.; Bellandi, F., 2014:
Statin and clopidogrel pharmacological interaction

Nomura, S., 2008:
Statin and endothelial cell-derived microparticles

Mascitelli, L.; Goldstein, M.R., 2013:
Statin and exercise prescription

Golubic, R.; Ray, K.Kumar., 2013:
Statin and exercise prescription

Dembowski, E.; Davidson, M.H., 2009:
Statin and ezetimibe combination therapy in cardiovascular disease

de Vries, R.; Dikkeschei, B.D.; Sluiter, W.J.; Dallinga-Thie, G.M.; van Tol, A.; Dullaart, R.P.F., 2013:
Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus

Shanafelt, T.D.; Rabe, K.G.; Kay, N.E.; Zent, C.S.; Call, T.G.; Slager, S.L.; Bowen, D.A.; Schwager, S.M.; Nowakowski, G.S., 2010:
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

McClure, D.L.; Valuck, R.J.; Glanz, M.; Murphy, J.R.; Hokanson, J.E., 2007:
Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population

Bangalore, S.; Fayyad, R.; Hovingh, G.Kees.; Laskey, R.; Vogt, L.; DeMicco, D.A.; Waters, D.D., 2014:
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials

Jose, J.; Al-Tamimi, F.Abdullah.Ali.; Helal, M.Mahmoud.; Jimmy, B.; A.R.yami, Q., 2014:
Statin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of oman

Fujita, E.; Shimizu, A.; Masuda, Y.; Kuwahara, N.; Arai, T.; Nagasaka, S.; Aki, K.; Mii, A.; Natori, Y.; Iino, Y.; Katayama, Y.; Fukuda, Y., 2010:
Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages

Vos, E.; Mascitelli, L.; Langsjoen, P.H., 2008:
Statin contraindicated in heart failure

Ohsfeldt, R.L.; Gandhi, S.K.; Fox, K.M.; McKenney, J.M., 2008:
Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications

Collins, R.; Meade, T.; Sleight, P.; Armitage, J.; Parish, S.; Peto, R.; Youngman, L.; Buxton, M.; de Bono, D.; George, C.; Fuller, J.; Keech, A.; Mansfield, A.; Pentecost, B.; Simpson, D.; Warlow, C.; McNamara, J.; O'Toole, L.; Doll, R.; Wilhelmsen, L.; Fox, K.M.; Hill, C.; Sandercock, P.; Benjamin, N.; Webster, J.; Jamieson, J.; Donald, L.; Blandford, R.; Carrington, L.; McMahon, H.; Cheetham, D.; Reckless, J.; Brice, L.; Carpenter, R.; Christmas, J.; Flower, C.; Cooper, I.; Frampton, S.;, 2010:
Statin cost-effectiveness in the United States for people at different vascular risk levels

Einecke, D., 2009:
Statin cuts cardiovascular risk in half

Celik, T.; Demirkol, S., 2012:
Statin dilemma in the management of chronic heart failure

Gomez Sandoval, Y-Haydee.; Braganza, M.V.; Daskalopoulou, S.S., 2013:
Statin discontinuation in high-risk patients: a systematic review of the evidence

Tjia, J.; Cutrona, S.L.; Peterson, D.; Reed, G.; Andrade, S.E.; Mitchell, S.L., 2015 :
Statin discontinuation in nursing home residents with advanced dementia

Tziomalos, K.; Athyros, V.G.; Mikhailidis, D.P., 2008:
Statin discontinuation: an underestimated risk?

Paraskevas, K.I.; Koupidis, S.; Gentimi, F.; Tzovaras, A.A., 2012:
Statin discontinuation: counterbalancing the benefits with the potential risks

Wang, P., 2012:
Statin dose in Asians: is pharmacogenetics relevant?

Kaesemeyer, W., 2010:
Statin drug eluting stent (DES) for early stent thrombosis

Bellosta, S.; Corsini, A., 2013:
Statin drug interactions and related adverse reactions

Platz, E.A.; Tangen, C.M.; Goodman, P.J.; Till, C.; Parnes, H.L.; Figg, W.D.; Albanes, D.; Neuhouser, M.L.; Klein, E.A.; Lucia, M.Scott.; Thompson, I.M.; Kristal, A.R., 2014:
Statin drug use is not associated with prostate cancer risk in men who are regularly screened

Rákóczi, Károly.; Párdutz, Aád.; Vécsei, László., 2007:
Statin drugs decrease the plasma level of coenzyme Q10 (ubiquinone) in the organism

Klinefelter, G.R.; Laskey, J.W.; Amann, R.P., 2015:
Statin drugs markedly inhibit testosterone production by rat Leydig cells in vitro: implications for men

Zeki, A.A.; Kenyon, N.J.; Goldkorn, T., 2011:
Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research

Mondul, A.M.; Selvin, E.; D.M.rzo, A.M.; Freedland, S.J.; Platz, E.A., 2010:
Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004

McLain, K.; Edlund, B.J., 2012:
Statin drugs: reducing cardiovascular risk in older adults

Khattab, A.A.; Ndrepepa, G.; Schulz, S.; Neumann, F-Josef.; Mehilli, J.; Büttner, H.Joachim.; Pache, Jürgen.; Seyfarth, M.; Dirschinger, J.; Kastrati, A.; Berger, P.B.; Schömig, A.; Richardt, G., 2011:
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial

Wanner, C., 2009:
Statin effects in CKD: is there a "point of no return"?

Gupta, M.; Braga, M.F.B.; Teoh, H.; Tsigoulis, M.; Verma, S., 2009:
Statin effects on LDL and HDL cholesterol in South Asian and white populations

Shavakhi, A.; Minakari, M.; Bighamian, A.; Sadeghian, S.; Shavakhi, S.; Khamisi, N.; Khodadustan, M.; Talebi, M.; Ataei, B., 2014:
Statin efficacy in the treatment of hepatitis C genotype I

Tse, S.Man.; Li, L.; Butler, M.G.; Fung, V.; Kharbanda, E.O.; Larkin, E.K.; Vollmer, W.M.; Miroshnik, I.; Rusinak, D.; Weiss, S.T.; Lieu, T.; Wu, A.Chen., 2013:
Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use

Kinoshita, T.; Asai, T.; Nishimura, O.; Hiramatsu, N.; Suzuki, T.; Kambara, A.; Matsubayashi, K., 2010:
Statin for prevention of atrial fibrillation after off-pump coronary artery bypass grafting in Japanese patients

Scheen, A.J.; Radermecker, R.P.; Sadzot, B., 2008:
Statin for the brain: update in 2008

Koo, B.Kyung., 2014:
Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus

Schulze, J.; Glass, X., 2013:
Statin hepatotoxicity and the dilemma of causality in rare hepatic adverse drug reactions

Mascitelli, L.; Goldstein, M.R., 2015:
Statin immunomodulation and thyroid cancer

Takenaka, T.; Takane, H.; Kikuta, T.; Watanabe, Y.; Suzuki, H., 2014:
Statin improves flow-mediated vasodilation in chronic kidney diseases

Bouchard, D.; Carrier, M.; Demers, P.; Cartier, R.; Pellerin, M.; Perrault, L.P.; Lambert, J., 2011:
Statin in combination with β-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery

Zen, Bárbara.; Rossi, L.; Rosa, E.Maffini.da., 2012:
Statin in prevention of atrial fibrillation after cardiac surgery

Clergeau, M-Rose.; Morello, Rémy.; Lepage, O.; Hamon, M., 2008:
Statin in prevention of periprocedural myonecrosis after percutaneous coronary angioplasty: systematic review and meta-analysis

Mascitelli, L.; Pezzetta, F.; Goldstein, M.R., 2010:
Statin induced angiogenesis and tumour growth

Aiman, U.; Najmi, A.; Khan, R.Ali., 2014:
Statin induced diabetes and its clinical implications

Molokhia, M.; McKeigue, P.; Curcin, V.; Majeed, A., 2008:
Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006

Rodine, R.J.; Tibbles, A.C.; Kim, P.Sy.; Alikhan, N., 2010:
Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients

Lines, S.W.; Lewington, A.J.P., 2008:
Statin induced myopathy. Dipstick test for myoglobinuria

White, C., 2008:
Statin induced myopathy. SEARCH genome study's results

Camilleri, B., 2008:
Statin induced myopathy. Use of statins with ciclosporin

Park, Y.Hee.; Jung, H.Hyun.; Ahn, J.Seok.; Im, Y-Hyuck., 2013:
Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway

Hisada, T.; Ayaori, M.; Ohrui, N.; Nakashima, H.; Nakaya, K.; Uto-Kondo, H.; Yakushiji, E.; Takiguchi, S.; Terao, Y.; Miyamoto, Y.; Adachi, T.; Nakamura, H.; Ohsuzu, F.; Ikewaki, K.; Sakurai, Y., 2012:
Statin inhibits hypoxia-induced endothelin-1 via accelerated degradation of HIF-1α in vascular smooth muscle cells

Lee, J-Koo.; Won, J-Seong.; Singh, A.K.; Singh, I., 2008:
Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death

Bohensky, M.; Tacey, M.; Brand, C.; Sundararajan, V.; Wicks, I.; Van Doornum, S., 2015:
Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population

Stafford, L.; Harmer, N.; Dhaliwal, S.; Jiwa, M., 2010:
Statin initiation by GPs in WA--a structured vignette study

Guyton, J.R.; Campbell, K.B.; Lakey, W.C., 2014:
Statin intolerance: more questions than answers

Sikka, P.; Kapoor, S.; Bindra, V.K.; Sharma, M.; Vishwakarma, P.; Saxena, K.K., 2012:
Statin intolerance: now a solved problem

Matteucci, E.; Giampietro, O., 2013:
Statin intolerance: why and what to do - with a focus on diabetic people

Li, N.; Yang, Y-Jin., 2015:
Statin is a two-edged sword in liver enzyme

Phipps, R.P.; Blumberg, N., 2009:
Statin islands and PPAR ligands in platelets

Anonymous, 2012:
Statin label changes

Norris, D.M.; Anderson, J.R., 2013:
Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction

Nusca, A.; Melfi, R.; Patti, G.; Sciascio, G.Di., 2011:
Statin loading before percutaneous coronary intervention: proposed mechanisms and applications

Nusca, A.; Melfi, R.; Patti, G.; D.S.iascio, G., 2011:
Statin loading for acute coronary syndromes

Athyros, V.G.; Tziomalos, K.; Florentin, M.; Karagiannis, A.; Mikhailidis, D.P., 2010:
Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?

Hamilton, R.J.; Banez, L.L.; Aronson, W.J.; Terris, M.K.; Platz, E.A.; Kane, C.J.; Presti, J.C.; Amling, C.L.; Freedland, S.J., 2010:
Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database

Anonymous, 2009:
Statin medications may improve stroke outcomes, recovery

Radcliffe, K.A.; Campbell, W.W., 2008:
Statin myopathy

Phillips, P.S.; Haas, R.H., 2008:
Statin myopathy as a metabolic muscle disease

Pella, D., 2011:
Statin myopathy--rarity or reality?

Fung, E.C.; Crook, M.A., 2013:
Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge

Mammen, A.L.; Amato, A.A., 2011:
Statin myopathy: a review of recent progress

Sewright, K.A.; Clarkson, P.M.; Thompson, P.D., 2007:
Statin myopathy: incidence, risk factors, and pathophysiology

Keen, H.I.; Krishnarajah, J.; Bates, T.R.; Watts, G.F., 2015:
Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?

Needham, M.; Mastaglia, F.L., 2014:
Statin myotoxicity: a review of genetic susceptibility factors

Coulson, W.F., 2011:
Statin neuropathy?

Al-Waili, K.; Al-Dughaishi, T.; Al-Rasadi, K.; Bayoumi, R.; Banerjee, Y., 2012:
Statin of Preference to Treat Dyslipidaemia in Patients with Renal Dysfunction: Cues from (SATURN)

Camerino, G.Maria.; Pellegrino, M.Antonietta.; Brocca, L.; Digennaro, C.; Camerino, D.Conte.; Pierno, S.; Bottinelli, R., 2011:
Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle

Hegg, R.; Lee, A.G.; Tagg, N.T.; Zimmerman, M.Bridget., 2011:
Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis

Kitzmiller, J.P.; Binkley, P.F.; Pandey, S.R.; Suhy, A.M.; Baldassarre, D.; Hartmann, K., 2014:
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes

Freiberger, T., 2008:
Statin pharmacokinetics

Kostapanos, M.S.; Liberopoulos, E.N.; Elisaf, M.S., 2009:
Statin pleiotropy against renal injury

Puri, R.; Tuzcu, E.Murat., 2013:
Statin pleiotropy in acute myocardial infarction--is it about timing?

Mirza, H.; Wu, Z.; Teo, J.D.W.; Tan, K.S.W., 2013:
Statin pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by Blastocystis cysteine proteases

Robinson, J.G.; Schrott, H., 2007:
Statin pleiotropy: a popular concept but clinical significance unclear

Fras, Z.; Mikhailidis, D.P., 2008:
Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice study

Parhofer, K., 2010:
Statin plus niacin or ezetimibe? What combination for which patients?

Wu, X.; Lin, D.; Li, G.; Zuo, Z., 2010:
Statin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells

Steen, D.L.; Bhatt, D.L., 2014:
Statin potency associated with incident diabetes in a real-world evaluation

Athyros, V.G.; Katsiki, N.; Karagiannis, A.; Mikhailidis, D.P., 2015:
Statin potency, LDL receptors and new onset diabetes

Yemisci, M.; Ay, H.; Kocaefe, C.; Qui, J.; Topalkara, K.; Ozgüç, M.; Kirazli, S.; Ozcebe, O.; Moskowitz, M.A.; Dalkara, T., 2008:
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels

Anonymous, 2008:
Statin power

Alabbadi, I.; Crealey, G.; Turner, K.; Rafferty, T.; Keenan, L.; Murray, P.; McElnay, J.C., 2010:
Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework

Stimac, D.; Culig, J.; John, V., 2009:
Statin prescribing in the City of Zagreb (2001-2006) and their role in secondary prevention of cardiovascular events

Geleedst-D.V.oght, M.; Maitland-van der Zee, A-Hilse.; Schalekamp, T.; Mantel-Teeuwisse, A.; Jansen, P., 2010:
Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study

Bayliss, E.A.; Bronsert, M.R.; Reifler, L.M.; Ellis, J.L.; Steiner, J.F.; McQuillen, D.B.; Fairclough, D.L., 2013:
Statin prescribing patterns in a cohort of cancer patients with poor prognosis

Vrdoljak, D.; Bergman Marković, B.; Kranjcević, K., 2010:
Statin prescription by Croatian family doctors lack of systematic proactive approach to cardiovascular disease prevention

Brugts, J.J.; Deckers, J.W., 2010:
Statin prescription in men and women at cardiovascular risk: to whom and when?

Nanchen, D.; Chiolero, A.; Marques-Vidal, P-Manuel.; Cornuz, J.; Waeber, Gérard.; Vollenweider, P.; Rodondi, N., 2010:
Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?

Leyon, J.J.; Jaiveer, S.; Connolly, D.L.; Babu, S., 2010:
Statin prescription is essential in peripheral vascular disease

Trusler, D., 2012:
Statin prescriptions in UK now total a million each week

Ndrepepa, G.; Fusaro, M.; King, L.; Cassese, S.; Tada, T.; Schömig, A.; Kastrati, A., 2014:
Statin pretreatment and presentation patterns in patients with coronary artery disease

Martínez-Comendador, Jé.; Alvarez, Jé.Rubio.; Bengochea, Jé.Benito.Garcia., 2011:
Statin pretreatment diminishes the levels of myocardial ischemia markers not only in CABG

Almeida, Jé.Luiz.; Sampietre, S.Nassa.; Mendonça Coelho, A.Maria.; Trindade Molan, N.Aparecida.; Machado, M.Cerqueira.César.; Monteiro da Cunha, Jé.Eduardo.; Jukemura, Jé., 2008:
Statin pretreatment in experimental acute pancreatitis

Moran, L.; Fugate, T.; Xiang, Y.; Cianci, C.; Matsumura, M., 2008:
Statin pretreatment is protective despite an association with greater coronary artery disease burden in patients presenting with a first ST-elevation myocardial infarction

Yudoh, K.; Karasawa, R., 2011:
Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA)

Nakamura, K.; Sasaki, T.; Cheng, X.Wu.; Iguchi, A.; Sato, K.; Kuzuya, M., 2009:
Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation

Morgan, C.; Zappitelli, M.; Gill, P., 2010:
Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review

Fedson, D.S., 2007:
Statin protection against influenza and COPD mortality

Pineda, A.; Cubeddu, L.X., 2011:
Statin rebound or withdrawal syndrome: does it exist?

HUANG.X.sheng.; ZHAO.S.ping.; BAI.L.; ZHANG.Q.; HU.M.; ZHAO.W., 2011:
Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats

Willrich, M.Alice.Vieira.; Hirata, M.Hiroyuki.; Hirata, R.Dominguez.Crespo., 2009:
Statin regulation of CYP3A4 and CYP3A5 expression

Okeahialam, B.N.; Isiguzoro, I., 2012:
Statin related memory dysfunction in a Nigerian woman: a case report

Terblanche, M.; Adhikari, N.K.J., 2010:
Statin research in critical illness: hampered by poor trial design?

Al-Sarraf, A.; Li, M.; Frohlich, J., 2013:
Statin resistant dyslipidemia in a patient treated with amiodarone

Brasileiro-Santos, M.S.; Barreto-Filho, Jé.A.S.; Santos, R.D.; Chacra, A.P.M.; Sangaleti, C.Teles.; Alvez, G.; Bezerra, O.Coelho.; Bortoloto, L.Aparecido.; Irigoyen, M.C.; Consolim-Colombo, F.M., 2014:
Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia

Wright, J.L.; Zhou, S.; Preobrazhenska, O.; Marshall, C.; Sin, D.D.; Laher, I.; Golbidi, S.; Churg, A.M., 2011:
Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling

Cash, J.; Callender, M.E.; McDougall, N.I.; Young, I.S.; Nicholls, D.P., 2009:
Statin safety and chronic liver disease

Anonymous, 2014:
Statin side effects: how common are they? You are unlikely to experience side effects from these drugs. If you do, there are ways to reverse them

Drazen, J.M.; Gelijns, A.C., 2014:
Statin strikeout

Kuijk, L.M.; Mandey, S.H.; Schellens, I.; Waterham, H.R.; Rijkers, G.T.; Coffer, P.J.; Frenkel, J., 2008:
Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1

Milionis, H.J.; Giannopoulos, S.; Kosmidou, M.; Panoulas, V.; Manios, E.; Kyritsis, A.P.; Elisaf, M.S.; Vemmos, K., 2009:
Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival

Suckow, B.D.; Kraiss, L.W.; Schanzer, A.; Stone, D.H.; Kalish, J.; DeMartino, R.R.; Cronenwett, J.L.; Goodney, P.P., 2015:
Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival

Worthley, S.G.; Helft, Gérard.; Corti, R.; Worthley, M.I.; Chew, D.P.; Fayad, Z.A.; Zaman, A.G.; Fallon, J.T.; Fuster, V.; Badimon, J.J., 2008:
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis

Ballantyne, C.M.; Raichlen, J.S.; Cain, V.A., 2008:
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial

Hariparshad, S.P.; Madala, N.D.; Assounga, A.G.H., 2010:
Statin therapy ameliorates renal allograft function

Loomba, R.Seth.; Arora, R., 2010:
Statin therapy and aortic stenosis: a systematic review of the effects of statin therapy on aortic stenosis

Fauchier, L.; Clementy, N.; Babuty, D., 2013:
Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials

Lei, L.; Zhang, X.; Mao, Y.; Lin, X.; Yang, L.; Li, Y.; Dong, S.; Wang, Y., 2015:
Statin therapy and bone marrow CD34+ cell frequency in type 2 diabetes mellitus: a cross-sectional study

Windler, E.; Nitschmann, S., 2014:
Statin therapy and cancer-related mortality

Fernandes, I.A.; Vianna, L.C.; Freitas, R.A.; Miranda, S.Marina.; Mesquita, E.Tinoco.; Mesquita, C.Tinoco.; da Nóbrega, A.Claudio.Lucas., 2015:
Statin therapy and cardiac sympathetic activity in patients with heart failure: a 123iodine-metaiodobenzylguanidine myocardial scintigraphy study

Robinson, D.A.; Ghaly, B.; Hayen, A.; Lusby, R.J., 2009:
Statin therapy and carotid endarterectomy: a review of trends in New South Wales, 1990-2004

Hermans, M.P.; Ahn, S.A.; Rousseau, M.F., 2011:
Statin therapy and cataract in type 2 diabetes

Brown, T.T.; Smurzynski, M.; Wu, K.; Bosch, R.J.; McComsey, G.A., 2009:
Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort

Ouzounian, M.; Tu, J.V.; Austin, P.C.; Chong, A.; Liu, P.P.; Lee, D.S., 2009:
Statin therapy and clinical outcomes in heart failure: a propensity-matched analysis

Strandberg, T.; Strandberg, A., 2013:
Statin therapy and cognition

Jansen, J.F.A., 2008:
Statin therapy and cognitive deficits associated with neurofibromatosis type 1

Bouzas-Mosquera, A.; Vázquez-Rodríguez, Jé.M.; Calviño-Santos, Rón.; Vázquez-González, Nás.; Castro-Beiras, A., 2008:
Statin therapy and contrast-induced nephropathy after primary angioplasty

Spanakis, E.K.; Kourkoumpetis, T.K.; Livanis, G.; Peleg, A.Y.; Mylonakis, E., 2011:
Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery

Florescu, M.C.; Birch, N., 2013:
Statin therapy and hemodialysis vascular access--were we bringing a knife to a gunfight and were hoping to win?

Kalantari, S.; Naghipour, M., 2014:
Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients

Corona, A., 2007:
Statin therapy and infection-related mortality

Kumbhani, D.J.; Steg, P.Gabriel.; Cannon, C.P.; Eagle, K.A.; Smith, S.C.; Goto, S.; Ohman, E.Magnus.; Elbez, Y.; Sritara, P.; Baumgartner, I.; Banerjee, S.; Creager, M.A.; Bhatt, D.L., 2015:
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry

Roik, M.; Starczewska, Młgorzata.H.; Huczek, Z.; Kochanowski, J.; Opolski, G., 2009:
Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report

Rasmussen, L.D.; Kronborg, G.; Larsen, C.S.; Pedersen, C.; Gerstoft, J.; Obel, N., 2013:
Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study

Abel, Tána.; Fehér, János., 2009:
Statin therapy and muscle disorders

Preiss, D., 2012:
Statin therapy and new-onset diabetes: a cause for concern?

Banach, M.; Malodobra-Mazur, M.; Gluba, A.; Katsiki, N.; Rysz, J.; Dobrzyn, A., 2014:
Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance

Ní Chróinín, D.; Asplund, K.; Åsberg, S.; Callaly, E.; Cuadrado-Godia, E.; Díez-Tejedor, E.; D.N.poli, M.; Engelter, S.T.; Furie, K.L.; Giannopoulos, S.; Gotto, A.M.; Hannon, N.; Jonsson, F.; Kapral, M.K.; Martí-Fàbregas, J.; Martínez-Sánchez, P.; Milionis, H.J.; Montaner, J.; Muscari, A.; Pikija, S.; Probstfield, J.; Rost, N.S.; Thrift, A.G.; Vemmos, K.; Kelly, P.J., 2013:
Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials

Ruscica, M.; Macchi, C.; Morlotti, B.; Sirtori, C.R.; Magni, P., 2015:
Statin therapy and related risk of new-onset type 2 diabetes mellitus

Rajpathak, S.N.; Kumbhani, D.J.; Crandall, J.; Barzilai, N.; Alderman, M.; Ridker, P.M., 2009:
Statin therapy and risk of developing type 2 diabetes: a meta-analysis

Skoumas, J.; Liontou, C.; Chrysohoou, C.; Masoura, C.; Aznaouridis, K.; Pitsavos, C.; Stefanadis, C., 2015:
Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia

Braamskamp, M.J.A.M.; Tsimikas, S.; Wiegman, A.; Kastelein, J.J.P.; Hutten, B.A., 2013:
Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia

Henderson, L.M.; Patel, S.; Giordano, T.P.; Green, L.; El-Serag, H.B., 2010:
Statin therapy and serum transaminases among a cohort of HCV-infected veterans

Benn, M., 2016:
Statin therapy and the development of diabetes mellitus

Draeger, A.; Sanchez-Freire, Vónica.; Monastyrskaya, K.; Hoppeler, H.; Mueller, M.; Breil, F.; Mohaupt, M.G.; Babiychuk, E.B., 2010:
Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle

McKinney, J.S.; Kostis, W.J., 2012:
Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials

Bliden, K.P.; Singla, A.; Gesheff, M.G.; Toth, P.P.; Tabrizchi, A.; Ens, G.; Guyer, K.; Singh, M.; Franzese, C.J.; Stapleton, D.; Tantry, U.S.; Gurbel, P.A., 2015:
Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin

Drolz, A., 2016:
Statin therapy as a protective factor regarding development of hypoxic hepatitis

Bajwa, E.K.; Malhotra, C.K.; Thompson, B.Taylor.; Christiani, D.C.; Gong, M.N., 2012:
Statin therapy as prevention against development of acute respiratory distress syndrome: an observational study

Mascitelli, L.; Goldstein, M.R.; Pezzetta, F., 2009:
Statin therapy as the fundamental therapy for cardiovascular prevention: be careful

Correale, M.; Brunetti, N.Daniele.; Totaro, A.; Montrone, D.; Russo, A.Rita.; Fanigliulo, A.Maria.; Ieva, R.; D.B.ase, M., 2012:
Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry

Li, J.; Wang, X.; Zhang, Z.; Zou, J.; Chen, Y.; Wang, X.; Wu, J., 2015:
Statin therapy correlated CYP2D6 gene polymorphism and hyperlipidemia

Montoya, R.C.; LaSala, A.F., 2011:
Statin therapy decreases myocardial function as evaluated via strain imaging

Calza, L.; Trapani, F.; Bartoletti, M.; Manfredi, R.; Colangeli, V.; Borderi, M.; Grossi, G.; Motta, R.; Viale, P., 2012:
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors

Limprasertkul, A.; Fisher, N.M.; Awad, A.B.; Pendergast, D.R., 2012:
Statin therapy depresses fat metabolism in older individuals

Rengo, J.L.; Savage, P.D.; Toth, M.J.; Ades, P.A., 2014:
Statin therapy does not attenuate exercise training response in cardiac rehabilitation

Zafon, C.; Obiols, G.; Mesa, J., 2015:
Statin therapy does not influence in the form onset of differentiated thyroid carcinoma

McEvoy, J.W., 2011:
Statin therapy dose and risk of new-onset diabetes

Carlon, R.; Zanchetta, M., 2008:
Statin therapy enhance benefit of exercise training in patients with claudication intermittens

Koba, S., 2014:
Statin therapy for atherogenic hypertriglyceridemia

Molokwu, O.C., 2011:
Statin therapy for elevated hsCRP: more evidence is needed

Ridker, P.M., 2011:
Statin therapy for elevated hsCRP: what are the public health implications?

Blaha, M.J.; Nasir, K.; Blumenthal, R.S., 2012:
Statin therapy for healthy men identified as "increased risk"

von Hippel, P., 2013:
Statin therapy for hyperlipidemia

Kostner, K.M., 2011:
Statin therapy for hypertrophic cardiomyopathy: too good to be true?

Ridker, P.M., 2010:
Statin therapy for low-LDL, high-hsCRP patients: from JUPITER to CORONA

Diehm, N., 2012:
Statin therapy for patients with abdominal aortic aneurysms

Holdaas, H., 2008:
Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?

Taylor, F.C.; Huffman, M.; Ebrahim, S., 2013:
Statin therapy for primary prevention of cardiovascular disease

Bangalore, S.; Messerli, F.H., 2013:
Statin therapy for secondary prevention: is there a gender difference? Test for interaction in meta-analysis revisited

Villines, T.C., 2012:
Statin therapy for subclinical atherosclerosis in primary prevention: time to prove it?

Angermann, C.E.; Nitschmann, S., 2008:
Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)

Jialal, I.; Devaraj, S., 2009:
Statin therapy for the metabolic syndrome: the evidence base

Negi, S.; Shukrullah, I.; Veledar, E.; Bloom, H.L.; Jones, D.P.; Dudley, S.C., 2012:
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)

Wang, Z.; Zhang, Y.; Gao, M.; Wang, J.; Wang, Q.; Wang, X.; Su, L.; Hou, Y., 2012:
Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials

Dickerson, J.E.; Slade, H.B., 2015:
Statin therapy for venous ulcers

Deo, S.V.; Rababa'h, A.; Altarabsheh, S.E.; Lim, J.Yong.; Cho, Y.Hyun.; Park, S.J., 2015:
Statin therapy improves long-term survival in non-ischaemic cardiomyopathy: a pooled analysis of 4500 patients

Fedoruk, L.M.; Wang, H.; Conaway, M.R.; Kron, I.L.; Johnston, K.C., 2008:
Statin therapy improves outcomes after valvular heart surgery

Zhu, Q.; Li, N.; Han, Q.; Zhang, P.; Yang, C.; Zeng, X.; Chen, Y.; Lv, Y.; Liu, X.; Liu, Z., 2013:
Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis

Rao, G.A.; Pandya, P.K., 2011:
Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C

Dalal, P.; Arora, R., 2010:
Statin therapy in South Asians-facts and future

Jaumdally, J.Rumi.; Varma, C.; Lip, G.Y.H., 2007:
Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?

Jialal, I.; Devaraj, S., 2007:
Statin therapy in acute cardiovascular syndromes

Kihara, Y., 2013:
Statin therapy in chronic heart failure: frog prince or bare frog?

Hereu, P.; Vallano, A., 2009:
Statin therapy in geriatrics

D.G.nnaro, L.; Brunetti, N.Daniele.; Correale, M.; Buquicchio, F.; Caldarola, P.; D.B.ase, M., 2014:
Statin therapy in heart failure: for good, for bad, or indifferent?

Javaheri, A.; Rader, D.J.; Javaheri, S., 2014:
Statin therapy in heart failure: is it time for a second look?

Glatz, U., 2012:
Statin therapy in low-risk cardiac patients is particularly effective

van Leuven, S.I.; Mendez-Fernandez, Y.V.; Stroes, E.S.; Tak, P.P.; Major, A.S., 2011:
Statin therapy in lupus-mediated atherogenesis: two birds with one stone?

Devaraj, S.; Siegel, D.; Jialal, I., 2011:
Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?

Novo, G.; Noto, D.; Averna, M.; Novo, S., 2012:
Statin therapy in patients with aortic stenosis after the ASTRONOMER trial: is there still any space?

Park, H.Eun.; Cho, G-Yeong.; Yoon, Y.E.; Youn, T-Jin.; Chun, E-Ju.; Choi, S-Il.; Choi, D-Ju., 2014:
Statin therapy in patients with atypical chest pain and mild-to-moderate coronary stenosis on 64-slice multidetector coronary computed tomography; a retrospective propensity score matching analysis

Dasari, T.W.; Cohen, D.J.; Kleiman, N.S.; Keyes, M.J.; Yen, C-Hsing.; Hanna, E.B.; Saucedo, J.F., 2014:
Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry)

Tehrani, F.; Morrissey, R.; Phan, A.; Chien, C.; Schwarz, E.R., 2010:
Statin therapy in patients with diastolic heart failure

Roik, M., 2009:
Statin therapy in patients with heart failure and preserved left ventricular function

Mitka, M., 2011:
Statin therapy in primary CVD prevention remains a hot-button topic for some

Harrington, C.; Horne, A.; Hasan, R.K.; Blumenthal, R.S., 2010:
Statin therapy in primary prevention: new insights regarding women and the elderly

Bansback, N.; Ara, R.; Ward, S.; Anis, A.; Choi, H.K., 2009:
Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis

Szadkowska, I.; Stanczyk, A.; Aronow, W.S.; Kowalski, J.; Pawlicki, L.; Ahmed, A.; Banach, M., 2010:
Statin therapy in the elderly: a review

Goldstein, M.R.; Mascitelli, L.; Pezzetta, F., 2012:
Statin therapy in the elderly: might there be uncertainty in the majority?

Goldstein, M.R.; Mascitelli, L.; Pezzetta, F., 2008:
Statin therapy in the elderly: misconceptions

Lander, J.S.; Coplan, N.L., 2011:
Statin therapy in the perioperative period

Lee, Y.Lin.; Blaha, M.J.; Jones, S.R., 2011:
Statin therapy in the prevention and treatment of atrial fibrillation

Gutierrez, J.; Ramirez, G.; Rundek, T.; Sacco, R.L., 2012:
Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis

Mascitelli, L.; Pezzetta, F.; Goldstein, M.R., 2010:
Statin therapy in the secondary prevention of cerebrovascular events: is it really beneficial in clinical practice?

Shufelt, C.L.; Manson, J.E.; American College of Cardiology, 2015:
Statin therapy in women

Rosenberg, H.; Mascitelli, L.; Pezzetta, F.; Goldstein, M.R., 2011:
Statin therapy in women: concerns and caution

Pletcher, M.J.; Hulley, S.B., 2010:
Statin therapy in young adults: ready for prime time?

Yamagami, H.; Sakaguchi, M.; Furukado, S.; Hoshi, T.; Abe, Y.; Hougaku, H.; Hori, M.; Kitagawa, K., 2008:
Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients

Miron, V.E.; Zehntner, S.P.; Kuhlmann, T.; Ludwin, S.K.; Owens, T.; Kennedy, T.E.; Bedell, B.J.; Antel, J.P., 2009:
Statin therapy inhibits remyelination in the central nervous system

de Keyser, C.E.; Koehler, E.M.; Schouten, J.N.L.; Visser, L.E.; Hofman, A.; Janssen, H.L.A.; Stricker, B.H., 2015:
Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals

Raux, M.; Cochennec, Fédéric.; Becquemin, J-Pierre., 2012:
Statin therapy is associated with aneurysm sac regression after endovascular aortic repair

Donnino, M.W.; Cocchi, M.N.; Howell, M.; Clardy, P.; Talmor, D.; Cataldo, L.; Chase, M.; Al-Marshad, A.; Ngo, L.; Shapiro, N.I., 2009:
Statin therapy is associated with decreased mortality in patients with infection

Reed, R.M.; Iacono, A.; DeFilippis, A.; Jones, S.; Eberlein, M.; Lechtzin, N.; Girgis, R.E., 2011:
Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD

Clementi, A.; Kim, J.Chul.; Floris, M.; Cruz, D.N.; Garzotto, F.; Zanella, M.; Nalesso, F.; Brendolan, A.; Giavarina, D.; Soffiati, G.; Ronco, C., 2012:
Statin therapy is associated with decreased small, dense low-density lipoprotein levels in patients undergoing peritoneal dialysis

Mace, A.G.; Gantt, G.A.; Skacel, M.; Pai, R.; Hammel, J.P.; Kalady, M.F., 2013:
Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer

de Bruin, J.L.; Baas, A.F.; Heymans, M.W.; Buimer, M.G.; Prinssen, M.; Grobbee, D.E.; Blankensteijn, J.D.; Grobbee, D.E.; Blankensteijn, J.D.; Bak, A.A.A.; Buth, J.; Pattynama, P.M.; Verhoeven, E.L.G.; van Voorthuisen, A.E.; Blankensteijn, J.D.; Balm, R.; Buth, J.; Cuypers, P.W.M.; Grobbee, D.E.; Prinssen, M.; van Sambeek, M.R.H.M.; Verhoeven, E.L.G.; Baas, A.F.; Hunink, M.G.; van Engelshoven, J.M.; Jacobs, M.J.H.M.; de Mol, B.A.J.M.; van Bockel, J.H.; Balm, R.; Reekers, J.; Tielbeek, X.; Verhoe, 2014:
Statin therapy is associated with improved survival after endovascular and open aneurysm repair

Habis, M.; Wroblewski, K.; Bradaric, M.; Ismail, N.; Yamada, S.Diane.; Litchfield, L.; Lengyel, E.; Romero, I.L., 2015:
Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis

Stanworth, R.D.; Kapoor, D.; Channer, K.S.; Jones, T.Hugh., 2009:
Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes

Drolz, A.; Horvatits, T.; Michl, B.; Roedl, K.; Schellongowski, P.; Holzinger, U.; Zauner, C.; Heinz, G.; Madl, C.; Trauner, M.; Fuhrmann, V., 2015:
Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients

Siegel, G.J.; Chauhan, N.B.; Feinstein, D.L.; Li, G.; Larson, E.B.; Breitner, J.C.S.; Montine, T.J., 2008:
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

Papathanasiou, A.; Toumpoulis, I.K.; Milionis, H.J.; Kalantzi, K.; Katsouras, C.S.; Goudevenos, J., 2008:
Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery

Cho, Y.; Lee, M.Jung.; Choe, E.Yeong.; Jung, C.Hee.; Joo, D.Jin.; Kim, M.Soo.; Cha, B.Soo.; Park, J-Yeol.; Kang, E.Seok., 2014:
Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels

Pisoni, R.; Barker-Finkel, J.; Allo, M., 2010:
Statin therapy is not associated with improved vascular access outcomes

Anonymous, 2009:
Statin therapy may do much more than lower cholesterol. Research shows statins can lower the odds of cardiovascular events among low-risk heart patients, but the drugs aren't for everyone

Saso, S.; Vecht, J.A.; Rao, C.; Protopapas, A.; Ashrafian, H.; Leff, D.; Darzi, A.; Athanasiou, T., 2010:
Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence?

Banerjee, D.; Bhattacharyya, R., 2015:
Statin therapy may prevent development of tuberculosis in diabetic state

Zhou, Y.; Yuan, Y.; Cai, R-Rong.; Huang, Y.; Xia, W-Qing.; Yang, Y.; Wang, P.; Wei, Q.; Wang, S-Hua., 2014:
Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis

Karrowni, W.; Dughman, S.; Hajj, G.P.; Miller, F.J., 2012:
Statin therapy reduces growth of abdominal aortic aneurysms

Horiuchi, Y.; Hirayama, S.; Soda, S.; Seino, U.; Kon, M.; Ueno, T.; Idei, M.; Hanyu, O.; Tsuda, T.; Ohmura, H.; Miida, T., 2010:
Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels

Tsai, N-Wen.; Lee, L-Hui.; Huang, C-Ren.; Chang, W-Neng.; Chang, Y-Ting.; Su, Y-Jih.; Chiang, Y-Fang.; Wang, H-Chen.; Cheng, B-Chung.; Lin, W-Che.; Kung, C-Te.; Su, C-Min.; Lin, Y-Jun.; Lu, C-Hsien., 2015:
Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome

Parihar, S.P.; Guler, R.; Khutlang, R.; Lang, D.M.; Hurdayal, R.; Mhlanga, M.M.; Suzuki, H.; Marais, A.David.; Brombacher, F., 2014:
Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation

Liao, Y-Chieh.; Hsieh, Y-Cheng.; Hung, C-Ying.; Huang, J-Long.; Lin, C-Heng.; Wang, K-Yang.; Wu, T-Juey., 2014:
Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study

Tahara, N.; Tahara, A.; Narula, J.; Imaizumi, T., 2014:
Statin therapy resolves coronary artery inflammation

Xie, R-qin.; Cui, W.; Liu, F.; Yang, C.; Pei, W-na.; Lu, J-chao., 2008:
Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure

Goldstein, L.B., 2013:
Statin therapy should be discontinued in patients with intracerebral hemorrhage

Bustamante, A.; Montaner, J., 2013:
Statin therapy should not be discontinued in patients with intracerebral hemorrhage

Jacob, S.; Manickam, P.; Rathod, A.; Badheka, A.; Afonso, L.; Aravindhakshan, R., 2012 :
Statin therapy significantly reduces risk of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator

Jeong, H.Chang.; Ahn, Y.; Hong, Y.Joon.; Kim, J.Han.; Jeong, M.Ho.; Kim, Y.Jo.; Chae, S.Chull.; Cho, M.Chan., 2014:
Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein

Kastelein, J.J.P.; Bots, M.L., 2009:
Statin therapy with ezetimibe or niacin in high-risk patients

L.M.nach, Y.; Coriat, P.; Collard, C.D.; Riedel, B., 2008:
Statin therapy within the perioperative period

Korber, K.E., 2008:
Statin therapy works for patients who have type 2 diabetes

Puurunen, J.; Piltonen, T.; Puukka, K.; Ruokonen, A.; Savolainen, M.J.; Bloigu, R.; Morin-Papunen, L.; Tapanainen, J.S., 2014:
Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study

Kokkinos, P.; Faselis, C.; Myers, J.; Kokkinos, J.Peter.; Doumas, M.; Pittaras, A.; Kheirbek, R.; Manolis, A.; Panagiotakos, D.; Papademetriou, V.; Fletcher, R., 2014:
Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans

Scott, D.; Blizzard, L.; Fell, J.; Jones, G., 2010:
Statin therapy, muscle function and falls risk in community-dwelling older adults

Goldstein, M.R.; Mascitelli, L.; Pezzetta, F., 2010:
Statin therapy, muscle function and vitamin D

Semple, S.J., 2012:
Statin therapy, myopathy and exercise--a case report

Sadowitz, B.; Seymour, K.; Costanza, M.J.; Gahtan, V., 2011:
Statin therapy--Part II: Clinical considerations for cardiovascular disease

Kahri, J.; Syvänne, M., 2012:
Statin therapy--for whom?

Lepor, N.E., 2009:
Statin therapy. Avoiding statin-related muscle side effects

Torrillo, T.M.; Rosenblatt, M.A., 2010:
Statin therapy: the new perioperative "magic bullet" for all surgical procedures?

Wahawisan, J.; Tovar, J.M.; Granberry, M.C., 2014:
Statin therapy: when to think twice

Gandhi, S.; Garg, A.X., 2013:
Statin toxicity from macrolide antibiotic coprescription

Churchward, M.A.; Todd, K.G., 2015:
Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms

Lingsma, H.F.; Steyerberg, E.W.; Scholte op Reimer, W.J.M.; van Domburg, R.; Dippel, D.W.J.; Kleyweg, R.P.; Franke, C.L.; Dippel, D.W.J.; Hofstee, D.J.; de Jong, G.; van den Berg, J.S.P.; Schyns-Soeterboek, A.; Saxena, R.; Thomeer, E.; Vermeij, F.H.; Jansen, B.P.W.; de Kort, P.L.M.; van Oostenbrugge, R.J.; Beijerink, M.; Broers, H.; van den Dool, A.; Fransen, H.; Jansen, C.; Kamps, M.; Koppelaar, C.; Berkum, G.Middelveld-van.; van Rijn, C.W.; de Swart, E.A.M.; Tebbe, H.A.M.; van der Wal, M.; Ver, 2010:
Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?

Puato, M.; Zambon, A.; Faggin, E.; Rattazzi, M.; Pauletto, P., 2015:
Statin treatment and carotid plaque composition: a review of clinical studies

Stenvinkel, P.; Rodríguez-Ayala, E.; Massy, Z.A.; Qureshi, A.Rashid.; Barany, P.; Fellström, B.; Heimburger, O.; Lindholm, B.; Alvestrand, A., 2007:
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients

Biffi, A.; Devan, W.J.; Anderson, C.D.; Cortellini, L.; Furie, K.L.; Rosand, J.; Rost, N.S., 2011:
Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis

Peltonen, T.; Ohtonen, P.; Näpänkangas, J.; Ohukainen, P.; Ruskoaho, H.; Taskinen, P., 2012:
Statin treatment and gene expression of anti-atherogenic factor C-type natriuretic peptide system in stenotic aortic valves

Liu, M-Ta.; Lin, H-Hsin.; Sun, M-Tsung.; Lin, H-Fu.; Wu, Y-Chung., 2014:
Statin treatment and intracerebral hemorrhage prognosis

Björkhem-Bergman, L.; Bergman, P.; Andersson, J.; Lindh, J.D., 2010:
Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis

Brault, M.; Ray, J.; Gomez, Y-Haydee.; Mantzoros, C.S.; Daskalopoulou, S.S., 2014:
Statin treatment and new-onset diabetes: a review of proposed mechanisms

Nguyen, C.Dinh.; Andersson, C.; Jensen, T.Bo.; Gjesing, A.; Schjerning Olsen, A-Marie.; Malta Hansen, C.; Büller, H.; Torp-Pedersen, C.; Gislason, G.H., 2013:
Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study

Goldstein, L.B.; Amarenco, P.; Zivin, J.; Messig, M.; Altafullah, I.; Callahan, A.; Hennerici, M.; MacLeod, M.J.; Sillesen, H.; Zweifler, R.; Michael, K.; Welch, A., 2009:
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

Ray, K.K., 2014:
Statin treatment and the risk of recurrent pulmonary embolism

Leoncini, M.; Toso, A.; Maioli, M.; Tropeano, F.; Bellandi, F., 2013:
Statin treatment before percutaneous cononary intervention

Solis, A.Bratt.; Pilemann-Lyberg, S.; Gæde, P., 2016:
Statin treatment causes an increased risk of type 2 diabetes

Nishiyama, Y.; Ueda, M.; Otsuka, T.; Katsura, K-ichiro.; Abe, A.; Nagayama, H.; Katayama, Y., 2011:
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients

Steinberg, D., 2008:
Statin treatment does not cause cancer

Carrier, M.; Cossette, Mève.; Pellerin, M.; Hébert, Y.; Bouchard, D.; Cartier, R.; Demers, P.; Jeanmart, H.; Pagé, P.; Perrault, L.P., 2009:
Statin treatment equalizes long-term survival between patients with single and bilateral internal thoracic artery grafts

Kaski, J.C., 2012:
Statin treatment for all individuals with cholesterol concentrations above "target"?: "Primum non nocere"--Hippocratic oath

Kanbay, M.; Turgut, F.; Covic, A.; Goldsmith, D., 2009:
Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence

Watanabe, E.; Yamashita, T.; Suzuki, S.; Saikawa, T.; Hirai, M.; Yamazaki, T.; Ohtsu, H.; Ogawa, S.; Investigators, T.J-Rhythm., 2011:
Statin treatment for patients with paroxysmal atrial fibrillation

Greving, J.P.; Visseren, F.L.J.; de Wit, G.A.; Algra, A., 2011:
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis

Paraskevas, K.I., 2007:
Statin treatment for rheumatoid arthritis: a promising novel indication

Tian, L.; Chen, Y.; Li, C.; Zeng, Z.; Xu, Y.; Long, S.; Fu, M., 2013:
Statin treatment improves plasma lipid levels but not HDL subclass distribution in patients undergoing percutaneous coronary intervention

Selmer, R.; Sakshaug, S.; Skurtveit, S.; Furu, K.; Tverdal, A., 2009:
Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education

Schindler, C.; Guenther, K.; Hermann, C.; Ferrario, C.M.; Schroeder, C.; Haufe, S.; Jordan, J.; Kirch, W., 2015:
Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction

Al-Khaled, M.; Matthis, C.; Eggers, Jürgen., 2015:
Statin treatment in patients with acute ischemic stroke

Berkelhammer, C.; Lerma, E.V., 2012:
Statin treatment in patients with elevated liver enzymes: pitch to proceed

Ishihara, M., 2010:
Statin treatment in patients with metabolic syndrome and coronary artery disease

Rizzo, M.; Nikolic, D.; Banach, M.; Montalto, G., 2013:
Statin treatment in the elderly: how much do we know?

Spindler, S.R.; Li, R.; Dhahbi, J.M.; Yamakawa, A.; Mote, P.; Bodmer, R.; Ocorr, K.; Williams, R.T.; Wang, Y.; Ablao, K.P., 2012:
Statin treatment increases lifespan and improves cardiac health in Drosophila by decreasing specific protein prenylation

Strandberg, T.E.; Pitkala, K.H.; Tilvis, R.S., 2008:
Statin treatment is associated with clearly reduced mortality risk of cardiovascular patients aged 75 years and older

Katsargyris, A.; Klonaris, C.; Tsiodras, S.; Bastounis, E.; Giannopoulos, A.; Theocharis, S., 2012:
Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins

Lenglet, Sébastien.; Quercioli, A.; Fabre, M.; Galan, K.; Pelli, G.; Nencioni, A.; Bauer, I.; Pende, A.; Python, M.; Bertolotto, M.; Spinella, G.; Pane, B.; Palombo, D.; Dallegri, F.; Mach, Fçois.; Vuilleumier, N.; Montecucco, F., 2014:
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis

Phan, K.; Gomez, Y-Haydee.; Elbaz, L.; Daskalopoulou, S.S., 2015:
Statin treatment non-adherence and discontinuation: clinical implications and potential solutions

Vuorio, A.; Docherty, K.F.; Humphries, S.E.; Kuoppala, J.; Kovanen, P.T., 2013:
Statin treatment of children with familial hypercholesterolemia--trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?

Hamilton, A.M.; Boughner, D.R.; Drangova, M.; Rogers, K.A., 2011:
Statin treatment of hypercholesterolemic-induced aortic valve sclerosis

Uchida, Y.; Masui, T.; Sato, A.; Nagai, K.; Anazawa, T.; Takaori, K.; Uemoto, S., 2018:
Computer tomographic assessment of postoperative peripancreatic collections after distal pancreatectomy

Kern, D.M.; Balu, S.; Tunceli, O.; Anzalone, D., 2015:
Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III

Jensen, G.B.; Hilden, Jørgen.; Als-Nielsen, B.; Damgaard, M.; Hansen, Jørgen.Fischer.; Hansen, S.; Helø, O.H.; Hildebrandt, P.; Kastrup, J.; Kolmos, H.Jørn.; Kjøller, E.; Lind, I.; Nielsen, H.; Petersen, L.; Jespersen, C.M.; Gluud, C., 2010:
Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease

Hartner, A.; Klanke, B.; Cordasic, N.; Amann, K.; Schmieder, R.E.; Veelken, R.; Hilgers, K.F., 2009:
Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension

Gürpınar, T.; Ekerbiçer, N.; Harzadın, N.U.; Barut, T.; Tarakçı, F.; Tuglu, M.I., 2012:
Statin treatment reduces oxidative stress-associated apoptosis of sciatic nerve in diabetes mellitus

Björkhem-Bergman, L.; Backheden, M.; Söderberg Löfdal, K., 2015:
Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden

Koutouzis, M.; Paraskevas, K.I.; Rallidis, L.S.; Barbatis, C.; Nomikos, A.; Tzavara, V.; Tsopanomichalou, M.; Lioupis, C.; Bessias, N.; Andikopoulos, V.; Mikhailidis, D.P.; Kyriakides, Z.S., 2008:
Statin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markers

Bang, C.N.; Okin, P.M., 2014:
Statin treatment, new-onset diabetes, and other adverse effects: a systematic review

Gamboa, C.M.; Safford, M.M.; Levitan, E.B.; Mann, D.M.; Yun, H.; Glasser, S.P.; Woolley, J.Michael.; Rosenson, R.; Farkouh, M.; Muntner, P., 2014:
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease

Yoon, H.Eun.; Lim, S.Woo.; Piao, S.Guo.; Song, J-Hyun.; Kim, J.; Yang, C.Woo., 2015:
Statin upregulates the expression of klotho, an anti-aging gene, in experimental cyclosporine nephropathy

Cardwell, C.R.; Hicks, B.M.; Hughes, C.; Murray, L.J., 2014:
Statin use after colorectal cancer diagnosis and survival: a population-based cohort study

Cardwell, C.R.; Hicks, B.M.; Hughes, C.; Murray, L.J., 2015:
Statin use after diagnosis of breast cancer and survival: a population-based cohort study

Carey, I.M.; DeWilde, S.; Shah, S.M.; Harris, T.; Whincup, P.H.; Cook, D.G., 2012:
Statin use after first myocardial infarction in UK men and women from 1997 to 2006: Who started and who continued treatment?

Song, C.; Park, S.; Park, J.; Shim, M.; Kim, A.; Jeong, I.Gab.; Hong, J.Hyuk.; Kim, C-Soo.; Ahn, H., 2015:
Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer

Ritz, B.; Manthripragada, A.D.; Qian, L.; Schernhammer, E.; Wermuth, L.; Olsen, J.; Friis, S., 2010:
Statin use and Parkinson's disease in Denmark

Støvring, H.; Hansen, D.Gilså.; Jarlbaek, L.; Kildemoes, H.Wallach.; Lous, Jørgen.; Andersen, M., 2007:
Statin use and age at death: evidence of a flawed analysis

Zeki, A.A.; Oldham, J.; Wilson, M.; Fortenko, O.; Goyal, V.; Last, M.; Last, A.; Patel, A.; Last, J.A.; Kenyon, N.J., 2013:
Statin use and asthma control in patients with severe asthma

Gonzalez-Castellon, M.A.; Marshall, R.S., 2015:
Statin use and brain hemorrhage: real risk or unfounded fear?

Murtola, T.J.; Visvanathan, K.; Artama, M.; Vainio, H.; Pukkala, E., 2015:
Statin use and breast cancer survival: a nationwide cohort study from Finland

Bonovas, S.; Lytras, T.; Sitaras, N.M., 2014:
Statin use and breast cancer: do we need more evidence and what should this be?

Nigwekar, S.U.; Bhan, I.; Turchin, A.; Skentzos, S.C.; Hajhosseiny, R.; Steele, D.; Nazarian, R.M.; Wenger, J.; Parikh, S.; Karumanchi, A.; Thadhani, R., 2013:
Statin use and calcific uremic arteriolopathy: a matched case-control study

Boudreau, D.M.; Yu, O.; Johnson, J., 2010:
Statin use and cancer risk: a comprehensive review

Kostis, J.B.; Dobrzynski, J.M., 2014:
Statin use and cataract

Klein, B.E.K.; Lee, K.E.; Klein, R., 2014:
Statin use and cataracts

Kadam, U.T.; Blagojevic, M.; Belcher, J., 2014:
Statin use and clinical osteoarthritis in the general population: a longitudinal study

Chung, S-D.; Tsai, M-C.; Lin, H-C.; Kang, J-H., 2015:
Statin use and clinical outcomes among pneumonia patients

Gnjidic, D.; L.C.uteur, D.G.; Blyth, F.M.; Travison, T.; Rogers, K.; Naganathan, V.; Cumming, R.G.; Waite, L.; Seibel, M.J.; Handelsman, D.J.; McLachlan, A.J.; Hilmer, S.N., 2013:
Statin use and clinical outcomes in older men: a prospective population-based study

Raley, K.A.; Hutchison, A.M., 2014:
Statin use and cognitive changes in elderly patients with dementia

Bertagnolli, M.M.; Hsu, M.; Hawk, E.T.; Eagle, C.J.; Zauber, A.G.; Bertagnolli, M.M.; Hawk, E.T.; Eagle, C.J.; Zauber, A.G.; Kim, K.M.; Corle, D.; Rosenstein, R.; Tang, J.; Hess, T.; Wilton, A.; Hsu, M.; Anderson, W.; Doody, L.; Redston, M.; Geisinger, K.R.; Woloj, G.M.; Bagheri, D.; Crawford, A.; Schietrum, M.; Ladouceur, V.; Rosen, S.; Friedman, L.; Makuch, R.; Phillips, R.; Taylor, P.; Auerbach, S.; Barish, C.F.; Barringer, T.; Bennetts, R.W.; Blitstein, M.; Bruggen, J.; Carricaburu, P.; Chun, 2010:
Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial

S.S.uver, J.L.; Jacobsen, S.J.; Jacobson, D.J.; McGree, M.E.; Girman, C.J.; Nehra, A.; Roger, V.L.; Lieber, M.M., 2011:
Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms

Feng, L.; Yap, K.Bee.; Kua, E.Heok.; Ng, T.Pin., 2010:
Statin use and depressive symptoms in a prospective study of community-living older persons

Ingebrigtsen, T.S.; Marott, J.L.; Nordestgaard, Børge.G.; Lange, P.; Hallas, J.; Vestbo, Jørgen., 2015:
Statin use and exacerbations in individuals with chronic obstructive pulmonary disease

Marcella, S.W.; David, A.; Ohman-Strickland, P.A.; Carson, J.; Rhoads, G.G., 2012:
Statin use and fatal prostate cancer: a matched case-control study

Yu, O.; Boudreau, D.M.; Buist, D.S.M.; Miglioretti, D.L., 2008:
Statin use and female reproductive organ cancer risk in a large population-based setting

McCandless, L.C., 2013:
Statin use and fracture risk: can we quantify the healthy-user effect?

Miedema, I.; Uyttenboogaart, M.; Koopman, K.; D.K.yser, J.; Luijckx, G.J., 2010:
Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke

Chou, C-Ying.; Chou, Y-Ching.; Chou, Y-Jenq.; Yang, Y-Fan.; Huang, N., 2014:
Statin use and incident dementia: a nationwide cohort study of Taiwan

LaCroix, A.Z.; Gray, S.L.; Aragaki, A.; Cochrane, B.B.; Newman, A.B.; Kooperberg, C.L.; Black, H.; Curb, J.David.; Greenland, P.; Woods, N.F.; Nabel, E.; Rossouw, J.; Ludlam, S.; McGowan, J.; Ford, L.; Geller, N.; Prentice, R.; Anderson, G.; LaCroix, A.; Kooperberg, C.L.; Patterson, R.E.; McTiernan, A.; Stein, E.; Cummings, S.; Wassertheil-Smoller, S.; Rajkovic, A.; Manson, J.E.; Eaton, C.B.; Phillips, L.; Beresford, S.; Martin, L.; Chlebowski, R.; Michael, Y.; Caan, B.; Kotchen, J.Morley.; Howa, 2008:
Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study

Gorelick, P.B., 2012:
Statin use and intracerebral hemorrhage: evidence for safety in recurrent stroke prevention?

Mosshammer, D.; Lorenz, G.; Meznaric, S.; Schwarz, J.; Muche, R.; Mörike, K., 2009:
Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings

Livingstone, E.; Hollestein, L.M.; van Herk-Sukel, M.P.P.; van de Poll-Franse, L.; Joosse, A.; Schilling, B.; Nijsten, T.; Schadendorf, D.; de Vries, E., 2015:
Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study

Robinson, J.G.; Booth, B., 2011:
Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006

Miedema, I.; Uyttenboogaart, M.; Luijckx, G-Jan., 2012:
Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic stroke

De Jong, H.J.I.; Damoiseaux, J.G.M.C.; Vandebriel, R.J.; Souverein, P.C.; Gremmer, E.R.; Wolfs, M.; Klungel, O.H.; Van Loveren, H.; Cohen Tervaert, J.Willem.; Verschuren, W.M.Monique., 2014:
Statin use and markers of immunity in the Doetinchem cohort study

Haussen, D.C.; Henninger, N.; Kumar, S.; Selim, M., 2013:
Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage

Friedman, D.R.; Magura, L.A.; Warren, H.A.C.; Harrison, J.D.; Diehl, L.F.; Weinberg, J.Brice., 2011:
Statin use and need for therapy in chronic lymphocytic leukemia

Koenig, M.A.; Grega, M.A.; Bailey, M.M.; Pham, L.D.; Zeger, S.L.; Baumgartner, W.A.; McKhann, G.M., 2010:
Statin use and neurologic morbidity after coronary artery bypass grafting: A cohort study

Rashid, M.Ahmed., 2014:
Statin use and osteoarthritis

Herrington, W.G., 2012:
Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis

Turner, J.P.; Shakib, S.; Singhal, N.; Hogan-Doran, J.; Prowse, R.; Johns, S.; Thynne, T.; Bell, J.Simon., 2014:
Statin use and pain in older people with cancer: a cross-sectional study

West, B.; Williams, C.M.; Jilbert, E.; James, A.M.; Haines, T.P., 2015:
Statin use and peripheral sensory perception: a pilot study

Bhave, P.D.; Goldman, L.Elizabeth.; Vittinghoff, E.; Maselli, J.H.; Auerbach, A., 2013:
Statin use and postoperative atrial fibrillation after major noncardiac surgery

Nowakowski, G.S.; Maurer, M.J.; Habermann, T.M.; Ansell, S.M.; Macon, W.R.; Ristow, K.M.; Allmer, C.; Slager, S.L.; Witzig, T.E.; Cerhan, J.R., 2010:
Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era

Boudreau, D.M.; Yu, O.; Buist, D.S.M.; Miglioretti, D.L., 2008:
Statin use and prostate cancer risk in a large population-based setting

Nielsen, S.F.; Nordestgaard, Børge.G.; Bojesen, S.E., 2012:
Statin use and reduced cancer-related mortality

Klop, C.; Driessen, J.H.M.; de Vries, F., 2013:
Statin use and reduced cancer-related mortality

Dawwas, M.F., 2013:
Statin use and reduced cancer-related mortality

Guo, Y-Fang.; Hu, D-Yi., 2008:
Statin use and reduced prevalence of sepsis

Sørensen, H.Toft.; Riis, A.Hammerich.; Lash, T.L.; Pedersen, L., 2011:
Statin use and risk of amyotrophic lateral sclerosis and other motor neuron disorders

Asgari, M.M.; Tang, J.; Epstein, E.H.; Chren, M-Margaret.; Warton, E.Margaret.; Quesenberry, C.P.; Go, A.S.; Friedman, G.D., 2009:
Statin use and risk of basal cell carcinoma

Flick, E.Dawn.; Habel, L.A.; Chan, K.Arnold.; Haque, R.; Quinn, V.P.; Van Den Eeden, S.K.; Sternfeld, B.; Orav, E.J.; Seeger, J.D.; Quesenberry, C.P.; Caan, B.J., 2009:
Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study

Dublin, S.; Jackson, M.L.; Nelson, J.C.; Weiss, N.S.; Larson, E.B.; Jackson, L.A., 2009:
Statin use and risk of community acquired pneumonia in older people: population based case-control study

Page, V.J.; Davis, D.; Zhao, X.B.; Norton, S.; Casarin, A.; Brown, T.; Ely, E.Wesley.; McAuley, D.F., 2014:
Statin use and risk of delirium in the critically ill

Otte, C.; Zhao, S.; Whooley, M.A., 2012 :
Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study

Zeliger, H., 2012:
Statin use and risk of diabetes

Culver, A.L.; Ockene, I.S.; Ma, Y., 2013:
Statin use and risk of diabetes-reply

Etminan, M.; Samii, A.; Brophy, J.M., 2010:
Statin use and risk of epilepsy: a nested case-control study

Bodmer, M.; Brauchli, Y.B.; Krähenbühl, S.; Jick, S.S.; Meier, C.R., 2009:
Statin use and risk of gallstone disease followed by cholecystectomy

Kan, H-Ping.; Guo, W-Bin.; Tan, Y-Fa.; Zhou, J.; Liu, C-Dong.; Huang, Y-Qi., 2014:
Statin use and risk of gallstone disease: A meta-analysis

Fujii, T.; Nakabayashi, T.; Hashimoto, S.; Kuwano, H., 2009:
Statin use and risk of gastroduodenal ulcer and reflux esophagitis

McGlynn, K.A.; Divine, G.W.; Sahasrabuddhe, V.V.; Engel, L.S.; VanSlooten, A.; Wells, K.; Yood, M.Ulcickas.; Alford, S.Hensley., 2015:
Statin use and risk of hepatocellular carcinoma in a U.S. population

Shi, M.; Zheng, H.; Nie, B.; Gong, W.; Cui, X., 2015:
Statin use and risk of liver cancer: an update meta-analysis

Wang, J.; Li, C.; Tao, H.; Cheng, Y.; Han, L.; Li, X.; Hu, Y., 2014:
Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials

Tan, N.; Klein, E.A.; Li, J.; Moussa, A.S.; Jones, J.Stephen., 2011:
Statin use and risk of prostate cancer in a population of men who underwent biopsy

Chan, J.M.; Litwack-Harrison, S.; Bauer, S.R.; Daniels, N.A.; Wilt, T.J.; Shannon, J.; Bauer, D.C., 2012:
Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study

Gutt, R.; Tonlaar, N.; Kunnavakkam, R.; Karrison, T.; Weichselbaum, R.R.; Liauw, S.L., 2010:
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy

Jespersen, C.G.; Nørgaard, M.; Friis, Søren.; Skriver, C.; Borre, M., 2014:
Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010

Bansal, D.; Undela, K.; D'Cruz, S.; Schifano, F., 2013:
Statin use and risk of prostate cancer: a meta-analysis of observational studies

Wemmelund, H.; Høgh, A.; Hundborg, H.H.; Thomsen, R.W.; Johnsen, S.P.; Lindholt, J.S., 2014:
Statin use and rupture of abdominal aortic aneurysm

Terpak, K.; Guthrie, S.; Erickson, S., 2015:
Statin use and self-reported swimming performance in US masters swimmers

Gupta, R.; Plantinga, L.C.; Fink, N.E.; Melamed, M.L.; Coresh, J.; Fox, C.S.; Levin, N.W.; Powe, N.R., 2007:
Statin use and sepsis events [corrected] in patients with chronic kidney disease

Chenaud, C.; Merlani, P., 2007:
Statin use and sepsis in patients with chronic kidney disease

Vítek, L.; Muchová, L.; Zák, Aš., 2012:
Statin use and serum bilirubin levels

Maguire, M.G.; Ying, G-shuang.; McCannel, C.A.; Liu, C.; Dai, Y., 2009:
Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial

van der Tol, A.; Van Biesen, W.; Van Laecke, S.; Bogaerts, K.; D.L.mbaert, K.; Warrinnier, H.; Vanholder, R., 2012:
Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study

Agarwal, V.; Phung, O.J.; Tongbram, V.; Bhardwaj, A.; Coleman, C.I., 2011:
Statin use and the prevention of venous thromboembolism: a meta-analysis

Green, R.C.; McNagny, S.E.; Jayakumar, P.; Cupples, L.Adrienne.; Benke, K.; Farrer, L.A., 2006:
Statin use and the risk of Alzheimer's disease: the MIRAGE study

Motzkus-Feagans, C.Anne.; Pakyz, A.; Polk, R.; Gambassi, G.; Lapane, K.L., 2012:
Statin use and the risk of Clostridium difficile in academic medical centres

Samii, A.; Carleton, B.C.; Etminan, M., 2008:
Statin use and the risk of Parkinson disease: a nested case control study

Shalev, V.; Sror, M.; Goldshtein, I.; Kokia, E.; Chodick, G., 2011:
Statin use and the risk of age related macular degeneration in a large health organization in Israel

Kuo, C-Chun.; Chiu, H-Fen.; Lee, I-Ming.; Kuo, H-Wei.; Lee, C-Te.; Yang, C-Yuh., 2013:
Statin use and the risk of bladder cancer: a population-based case-control study

Chan, T-Fu.; Wu, C-Hsuan.; Lin, C-Lung.; Yang, C-Yuh., 2014:
Statin use and the risk of breast cancer: a population-based case-control study

Cheng, M-Hsuan.; Chiu, H-Fen.; Ho, S-Chen.; Tsai, S-Shyue.; Wu, T-Neng.; Yang, C-Yuh., 2012:
Statin use and the risk of colorectal cancer: a population-based case-control study

Anonymous, 2012:
Statin use and the risk of developing diabetes. Study confirms a link, but does the risk outweigh the benefits?

Chan, T-Fu.; Chiu, H-Fen.; Wu, C-Hsuan.; Lin, C-Lung.; Yang, C-Yuh., 2013:
Statin use and the risk of esophageal cancer: a population-based case-control study

Chiu, H-Fen.; Chen, C-Cheng.; Kuo, H-Wei.; Lee, I-Ming.; Wu, T-Neng.; Yang, C-Yuh., 2012:
Statin use and the risk of gallstone disease: a population-based case-control study

Colbert, J.D.; Stone, J.A., 2012:
Statin use and the risk of incident diabetes mellitus: a review of the literature

Chiu, H-Fen.; Kuo, C-Chun.; Kuo, H-Wei.; Lee, I-Ming.; Lee, C-Te.; Yang, C-Yuh., 2012:
Statin use and the risk of kidney cancer: a population-based case-control study

Chiu, H-Fen.; Chang, C-Ching.; Ho, S-Chen.; Wu, T-Neng.; Yang, C-Yuh., 2011:
Statin use and the risk of pancreatic cancer: a population-based case-control study

D'Amico, A.V., 2010:
Statin use and the risk of prostate-specific antigen recurrence after radiation therapy with or without hormone therapy for prostate cancer

Ishak-Howard, M.B.; Okoth, L.A.; Cooney, K.A., 2014:
Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer

Liu, W.; Choueiri, T.K.; Cho, E., 2012:
Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts

Daneman, N.; Thiruchelvam, D.; Redelmeier, D.A., 2009:
Statin use and the risk of surgical site infections in elderly patients undergoing elective surgery

Hung, S-Han.; Lin, H-Ching.; Chung, S-Dong., 2016:
Statin use and thyroid cancer: a population-based case-control study

Schmidt, M.; Cannegieter, S.C.; Johannesdottir, S.A.; Dekkers, O.M.; Horváth-Puhó, E.; Sørensen, H.T., 2015:
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study

Foody, J., 2010:
Statin use associated with increased risk of cataract, myopathy, liver dysfunction and acute renal failure with varying numbers needed to harm

Molnar, A.O.; Coca, S.G.; Devereaux, P.J.; Jain, A.K.; Kitchlu, A.; Luo, J.; Parikh, C.R.; Paterson, J.Michael.; Siddiqui, N.; Wald, R.; Walsh, M.; Garg, A.X., 2011:
Statin use associates with a lower incidence of acute kidney injury after major elective surgery

Salat, D.; Ribosa, R.; Garcia-Bonilla, L.; Montaner, J., 2010:
Statin use before and after acute ischemic stroke onset improves neurological outcome

Nielsen, S.F.; Nordestgaard, Børge.G., 2015:
Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study

de Saint Martin, L.; Tandé, D.; Goetghebeur, D.; Pan-Lamandé, M.; Segalen, Y.; Pasquier, E., 2010:
Statin use does not affect the outcome of acute infection: a prospective cohort study

Flint, A.C.; Kamel, H.; Navi, B.B.; Rao, V.A.; Faigeles, B.S.; Conell, C.; Klingman, J.G.; Sidney, S.; Hills, N.K.; Sorel, M.; Cullen, S.P.; Johnston, S.Claiborne., 2012:
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival

Kusters, D.Meeike.; Hassani Lahsinoui, H.; van de Post, J.A.M.; Wiegman, A.; Wijburg, F.A.; Kastelein, J.J.P.; Hutten, B.A., 2012:
Statin use during pregnancy: a systematic review and meta-analysis

Westover, M.Brandon.; Bianchi, M.T.; Eckman, M.H.; Greenberg, S.M., 2011:
Statin use following intracerebral hemorrhage: a decision analysis

D.V.cchis, R.; D.B.ase, G.; Esposito, C.; Ciccarelli, A.; Cioppa, C.; Giasi, A.; Ariano, C.; Cantatrione, S., 2014:
Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis

Gelissen, I.C.; Nguyen, H.Long.; Tiao, D.K.; Ayoub, R.; Aslani, P.; Moles, R., 2014:
Statin use in Australian children: a retrospective audit of four pediatric hospitals

Lawes, C.M.M.; Thornley, S.; Young, R.; Hopkins, R.; Marshall, R.; Chan, W.Cheuk.; Jackson, G., 2012:
Statin use in COPD patients is associated with a reduction in mortality: a national cohort study

Neutel, C.Ineke.; Morrison, H.; Campbell, N.R.C.; de Groh, M., 2007:
Statin use in Canadians: trends, determinants and persistence

Tse, S.Man.; Charland, S.L.; Stanek, E.; Herrera, V.; Goldfarb, S.; Litonjua, A.A.; Weiss, S.T.; Wu, A.Chen., 2014:
Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits

Lasky, T., 2008:
Statin use in children in the United States

Celik, T.; Iyisoy, A.; Dogru, M.Tolga.; Isik, E., 2007:
Statin use in chronic heart failure: waiting for the results of large prospective outcome trials

Schmidt, J.; Kermani, T.A.; Muratore, F.; Crowson, C.S.; Matteson, E.L.; Warrington, K.J., 2014:
Statin use in giant cell arteritis: a retrospective study

Frampton, S., 2008:
Statin use in nonischemic cardiomyopathy: review of the literature

Pulkkinen, J.; Kastarinen, H.; Kiviniemi, V.; Jyrkkä, J.; Juvonen, P.; Räty, S.; Paajanen, H., 2014:
Statin use in patients with acute pancreatitis and symptomatic gallstone disease

Huang, C-Chou.; Chan, W-Leong.; Chen, Y-Chun.; Chen, T-Ji.; Chou, K-Ta.; Lin, S-Jong.; Chen, J-Wen.; Leu, H-Bang., 2011:
Statin use in patients with asthma: a nationwide population-based study

Paraskevas, K.I.; Tzovaras, A.A.; Stathopoulos, V.; Mikhailidis, D.P., 2011:
Statin use in patients with chronic kidney disease stages 2-4: targeting beyond improved mortality rates

Kumar, S.; Grace, N.D.; Qamar, A.A., 2014:
Statin use in patients with cirrhosis: a retrospective cohort study

Koya, D.; Campese, V.M., 2013:
Statin use in patients with diabetes and kidney disease: the Japanese experience

Resh, M.; Mahmoodi, B.K.; Navis, G.J.; Veeger, N.J.G.M.; Lijfering, W.M., 2011:
Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism

Young, R.P.; Hopkins, R.J., 2013:
Statin use in pneumonia

Wild, S.H.; Byrne, C.D., 2012:
Statin use in postmenopausal women is associated with an increased risk of incident diabetes mellitus

Toms, T.E.; Panoulas, V.F.; Douglas, K.M.J.; Griffiths, H.; Sattar, N.; Smith, J.P.; Symmons, D.P.M.; Nightingale, P.; Metsios, G.S.; Kitas, G.D., 2010:
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

Hoeks, S.E.; Scholte, O.R.imer, W.J.; Schouten, O.; Lenzen, M.J.; van Urk, H.; Poldermans, D., 2008:
Statin use in the elderly: results from a peripheral vascular survey in The Netherlands

Nguyen, T.; Khalaf, N.; Ramsey, D.; El-Serag, H.B., 2014:
Statin use is associated with a decreased risk of Barrett's esophagus

Simon, T.G.; King, L.Y.; Zheng, H.; Chung, R.T., 2016:
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C

Tziakas, D.N.; Chalikias, G.K.; Stakos, D.; Tentes, I.K.; Thomaidi, A.; Chatzikyriakou, S.; Mitrousi, K.; Kortsaris, A.X.; Kaski, J.Carlos.; Boudoulas, H.; Konstantinides, S., 2010:
Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect?

Türk, Uğur.; Alioğlu, E.; Tengiz, I.; Ercan, Eğrul.; Mahmudov, Rşat.; Duygu, H.; Türkoğlu, Cüneyt., 2008:
Statin use is associated with decreased CD-40 ligand expression on T lymphocytes of coronary atheroma plaque in patients with stable coronary artery disease

Oh, D.S.; Koontz, B.; Freedland, S.J.; Gerber, L.; Patel, P.; Lewis, S.; Yoo, D.S.; Oleson, J.; Salama, J.K., 2016:
Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy

Welten, G.M.J.M.; Chonchol, M.; Schouten, O.; Hoeks, S.; Bax, J.J.; van Domburg, R.T.; van Sambeek, M.; Poldermans, D., 2008:
Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome

Lindy, O.; Suomalainen, K.; Mäkelä, M.; Lindy, S., 2008:
Statin use is associated with fewer periodontal lesions: A retrospective study

Dosluoglu, H.H.; Davari-Farid, S.; Pourafkari, L.; Harris, L.M.; Nader, N.D., 2014:
Statin use is associated with improved overall survival without affecting patency and limb salvage rates following open or endovascular revascularization

Murtola, T.J., 2010:
Statin use is associated with improved prostate cancer survival: is it time for a clinical trial?

Sumner, A.D.; Boehmer, J.P.; Saxon, L.A.; Carson, P.; Feldman, A.M.; Galle, E.; Bristow, M.R., 2009:
Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy

Pellegrini, C.N.; Vittinghoff, E.; Lin, F.; Hulley, S.B.; Marcus, G.M., 2009:
Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial

Wiesbauer, F.; Heinze, G.; Mitterbauer, C.; Harnoncourt, F.; Hörl, W.H.; Oberbauer, R., 2008:
Statin use is associated with prolonged survival of renal transplant recipients

Yi, X.; Jia, W.; Jin, Y.; Zhen, S., 2014:
Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis

Alexandre, L.; Clark, A.B.; Bhutta, H.Y.; Holt, S.; Lewis, M.P.N.; Hart, A.R., 2014:
Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis

Krens, L.L.; Simkens, L.H.J.; Baas, J.M.; Koomen, E.R.; Gelderblom, H.; Punt, C.J.A.; Guchelaar, H-Jan., 2016:
Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study

Younoszai, Z.; Li, Z.; Stepanova, M.; Erario, M.; Cable, R.; Younossi, Z.M., 2014:
Statin use is not associated with liver related mortality

Oni, E.T.; Sinha, P.; Karim, A.; Martin, S.S.; Blaha, M.J.; Agatston, A.S.; Blumenthal, R.S.; Meneghelo, R.S.; Conceiçao, R.D.; Santos, R.D.; Nasir, K., 2014:
Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease

Anonymous, 2012:
Statin use linked to increased risk of diabetes in older women. Risk of type 2 diabetes in postmenopausal women may be up to 48 percent higher than in women who do not use the cholesterol-lowering drugs, but the jury tilts in favor of continuing medication

Sendur, M.Ali.Nahit.; Aksoy, S.; Yazıcı, O.; Ozdemir, N.Y.; Zengin, N.; Altundag, K., 2014:
Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer

Voelker, R., 2014:
Statin use may stop when illness is terminal, study says

Hassan, Y.; Al-Jabi, S.W.; Aziz, N.Abd.; Looi, I.; Zyoud, S'ed.H., 2011:
Statin use prior to ischemic stroke onset is associated with decreased in-hospital mortality

Ritz, E.; Wanner, C., 2008:
Statin use prolongs patient survival after renal transplantation

Wu, C-K.; Yang, Y-H.; Lin, T-T.; Tsai, C-T.; Hwang, J-J.; Lin, J-L.; Chen, P-C.; Chiang, F-T.; Lin, L-Y., 2015:
Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis

Tseng, M-Yuan.; Hutchinson, P.J.; Turner, C.L.; Czosnyka, M.; Richards, H.K.; Pickard, J.D.; Kirkpatrick, P.J., 2008:
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

Anonymous, 2014:
Statin users eating more calories and fat

VanFossen, B.T.; Watson, G.Stennis.; Baker, L.D.; Rhoads, K.W.; Cholerton, B.A.; Reger, M.A.; Plymate, S.R.; Schellenberg, G.; Craft, S., 2010:
Statin users without an APOE-epsilon4 allele have increased insulin resistance

Parikh, S.; Shrank, W.H.; Mogun, H.; Choudhry, N.K., 2011:
Statin utilization in nursing home patients after cardiac hospitalization

Lee, V.W.Y.; Ho, I.C.H.; Chan, W.S.Y.; Tam, K.Yin.; Lee, K.K.C., 2008:
Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong

Prigent, B., 2007:
Statin wars following coronary revascularization - evidence-based clinical practice?

Wierzbicki, A.S., 2011:
Statin wars: efficacy vs. cost

Lavie, C.J.; Milani, R.V.; O'Keefe, J.H., 2007:
Statin wars: emphasis on potency vs event reduction and safety?

DiNicolantonio, J.J.; Lavie, C.J.; Serebruany, V.L.; O'Keefe, J.H., 2013:
Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease

Fallouh, N.; Chopra, V., 2013:
Statin withdrawal after major noncardiac surgery: risks, consequences, and preventative strategies

Tran, Y.B.L.; Frial, T.; Miller, P.S.J., 2007:
Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins

Ma, T.; Zhao, Y.; Kwak, Y-Don.; Yang, Z.; Thompson, R.; Luo, Z.; Xu, H.; Liao, F-Fang., 2009:
Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling

Hatem, S.; Boccara, F., 2008:
Statin, the black box

Athyros, V.G.; Kakafika, A.I.; Papageorgiou, A.A.; Pagourelias, E.D.; Savvatianos, S.D.; Elisaf, M.; Karagiannis, A.; Tziomalos, K.; Mikhailidis, D.P., 2008:
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients

Wu, Y.; Lach, B.; Provias, J.P.; Tarnopolsky, M.A.; Baker, S.K., 2016:
Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum

Panchangam, V., 2014:
Statin-associated acute interstitial nephritis and rhabdomyolysis

Evans, M.A.; Golomb, B.A., 2009:
Statin-associated adverse cognitive effects: survey results from 171 patients

Mohassel, P.; Mammen, A.L., 2013:
Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies

Meador, B.M.; Huey, K.A., 2012:
Statin-associated changes in skeletal muscle function and stress response after novel or accustomed exercise

Asbach, P.; Paetsch, I.; Stawowy, P.; Sander, B.; Fleck, E., 2007:
Statin-associated focal myositis

Roberto, G.; Biagi, C.; Montanaro, N.; Koci, A.; Moretti, U.; Motola, D., 2012:
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature

Park, Z.H.; Juska, A.; Dyakov, D.; Patel, R.V., 2015:
Statin-associated incident diabetes: a literature review

Fujimoto, M.; Hosomi, K.; Takada, M., 2014:
Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS

Cham, S.; Evans, M.A.; Denenberg, J.O.; Golomb, B.A., 2010:
Statin-associated muscle-related adverse effects: a case series of 354 patients

Sakaeda, T.; Kadoyama, K.; Okuno, Y., 2012:
Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system

Pasutharnchat, N.; Phanthumchinda, K., 2011:
Statin-associated myasthenic weakness

Meador, B.M.; Huey, K.A., 2010:
Statin-associated myopathy and its exacerbation with exercise

Fernandes, Górgea.Hermogenes.; Zanoteli, E.; Shinjo, S.Katsuyuki., 2015:
Statin-associated necrotizing autoimmune myopathy

de Jong, H.J.I.; Saldi, S.R.F.; Klungel, O.H.; Vandebriel, R.J.; Souverein, P.C.; Meyboom, R.H.B.; Passier, J.L.M.Anneke.; van Loveren, H.; Cohen Tervaert, J.Willem., 2012:
Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach

Kanth, R.; Shah, M.S.; Flores, R.Medina., 2014:
Statin-associated polymyositis following omeprazole treatment

Tuccori, M.; Lapi, F.; Testi, A.; Coli, D.; Moretti, U.; Vannacci, A.; Motola, D.; Salvo, F.; Rivolta, A.Lisa.; Blandizzi, C.; Mugelli, A.; Del Tacca, M., 2008:
Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting

Kar, S.; Chockalingam, A., 2013:
Statin-associated rhabdomyolysis with acute renal failure complicated by intradialytic NSTEMI: a review of lipid management considerations

Holbrook, A.; Wright, M.; Sung, M.; Ribic, C.; Baker, S., 2011:
Statin-associated rhabdomyolysis: is there a dose-response relationship?

Keogh, M.J.; Findlay, J.M.; Leach, S.; Bowen, J., 2010:
Statin-associated weakness in myasthenia gravis: a case report

Athyros, V.G.; Tziomalos, K.; Daskalopoulos, G.N.; Karagiannis, A.; Mikhailidis, D.P., 2011:
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?

Sassano, A.; Altman, J.K.; Gordon, L.I.; Platanias, L.C., 2013:
Statin-dependent activation of protein kinase Cδ in acute promyelocytic leukemia cells and induction of leukemic cell differentiation

Woodard, J.; Sassano, A.; Hay, N.; Platanias, L.C., 2008:
Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma

Frishman, W.H.; Horn, J., 2008:
Statin-drug interactions: not a class effect

Vareka, Tás.; Vítková, D.; Zeman, M.; Vecka, M.; Zák, A., 2012:
Statin-ezetimibe combination in hyperlipidemia treatment

Athyros, V.G.; Tziomalos, K.; Karagiannis, A.; Mikhailidis, D.P., 2010:
Statin-fibrate combination for mixed dyslipidaemia: a limited option?

Feeman, W.E., 2008:
Statin-fibrate combination therapy

Athyros, V.G.; Wierzbicki, A.S., 2014:
Statin-fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low

Ennishi, D.; Asai, H.; Maeda, Y.; Shinagawa, K.; Ikeda, K.; Yokoyama, M.; Terui, Y.; Takeuchi, K.; Yoshino, T.; Matsuo, K.; Hatake, K.; Tanimoto, M., 2010:
Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy

Hattori, T.; Saito, K.; Takemura, M.; Ito, H.; Ohta, H.; Wada, H.; Sei, Y.; Kawamura, M.; Seishima, M., 2010:
Statin-induced Ca(2+) release was increased in B lymphocytes in patients who showed elevated serum creatine kinase during statin treatment

Bu, D-xiu.; Tarrio, M.; Grabie, N.; Zhang, Y.; Yamazaki, H.; Stavrakis, G.; Maganto-Garcia, E.; Pepper-Cunningham, Z.; Jarolim, P.; Aikawa, M.; García-Cardeña, G.; Lichtman, A.H., 2010:
Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses

Fitzgerald, K.; Redmond, E.; Harbor, C., 2012:
Statin-induced Myopathy

Suchak, R.; Benson, K.; Swale, V., 2007:
Statin-induced Ro/SSa-positive subacute cutaneous lupus erythematosus

Ayer, R.E.; Ostrowski, R.P.; Sugawara, T.; Ma, Q.; Jafarian, N.; Tang, J.; Zhang, J.H., 2012:
Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage

Harangi, M.; Zsíros, Némi.; Juhász, L.; Paragh, Görgy., 2013:
Statin-induced adverse effects -- facts and genes

Yanae, M.; Tsubaki, M.; Satou, T.; Itoh, T.; Imano, M.; Yamazoe, Y.; Nishida, S., 2011:
Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma

Parikh, A.; Childress, C.; Deitrick, K.; Lin, Q.; Rukstalis, D.; Yang, W., 2010:
Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells

Alam, S.; Ueki, K.; Nakagawa, K.; Marukawa, K.; Hashiba, Y.; Yamamoto, E.; Sakulsak, N.; Iseki, S., 2008:
Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study

Kupcsik, L.; Meurya, T.; Flury, M.; Stoddart, M.; Alini, M., 2010:
Statin-induced calcification in human mesenchymal stem cells is cell death related

Bolotin, E.; Armendariz, A.; Kim, K.; Heo, S-Jin.; Boffelli, D.; Tantisira, K.; Rotter, J.I.; Krauss, R.M.; Medina, M.W., 2014:
Statin-induced changes in gene expression in EBV-transformed and native B-cells

Kerzner, S.; Irabagon, N.; Berkelhammer, C., 2014:
Statin-induced cholestatic hepatitis: confirmed on rechallenge

Abbasi, F.; Reaven, G.M., 2015:
Statin-induced diabetes: how important is insulin resistance?

Goldstein, M.R.; Mascitelli, L., 2011:
Statin-induced diabetes: perhaps, it's the tip of the iceberg

Turgeon, R.; Allan, G.Michael., 2014:
Statin-induced diabetes: too sweet a deal?

Belalcazar, L.Maria.; Raghavan, V.A.; Ballantyne, C.M., 2009:
Statin-induced diabetes: will it change clinical practice?

Edholm, B., 2010:
Statin-induced dysphagia

Wagner, M.; Mühldorfer-Fodor, M.; Prommersberger, K.J.; Schmitt, R., 2011:
Statin-induced focal myositis of the upper extremity. A report of two cases

Hsieh, C-Hua.; Jeng, S-Feng.; Hsieh, M-Wei.; Chen, Y-Chun.; Rau, C-Shyuan.; Lu, T-Hsiang.; Chen, S-Sheng., 2007:
Statin-induced heme oxygenase-1 increases NF-kappaB activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide

Ruggieri, A.; Gambardella, L.; Maselli, A.; Vona, R.; Anticoli, S.; Panusa, A.; Malorni, W.; Matarrese, P., 2014:
Statin-induced impairment of monocyte migration is gender-related

Kanugula, A.Koteswararao.; Gollavilli, P.Naidu.; Vasamsetti, S.Babu.; Karnewar, S.; Gopoju, R.; Ummanni, R.; Kotamraju, S., 2014:
Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms

Mitchell, P.; Marette, Aé., 2014:
Statin-induced insulin resistance through inflammasome activation: sailing between Scylla and Charybdis

Kromer, A.; Moosmann, B., 2009:
Statin-induced liver injury involves cross-talk between cholesterol and selenoprotein biosynthetic pathways

Cao, P.; Hanai, J-Ichi.; Tanksale, P.; Imamura, S.; Sukhatme, V.P.; Lecker, S.H., 2009:
Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect

Hedenmalm, K.; Granberg, A.Gunes.; Dahl, M-Liisa., 2015:
Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives

Ravnskov, U., 2010:
Statin-induced muscular problems are underestimated

Kumar, A.J.Shyam.; Wong, S.K.; Andrew, G., 2008:
Statin-induced muscular symptoms: a report of 3 cases

Lasker, S.S.; Chowdbury, T.A., 2013:
Statin-induced myalgia

Tomaszewski, Mł.; Stępień, K.M.; Tomaszewska, J.; Czuczwar, Sław.J., 2012:
Statin-induced myopathies

Gounden, R.; Blockman, M., 2008:
Statin-induced myopathy

Pearce, P.Z., 2008 :
Statin-induced myopathy in a competitive amateur cyclist

Martikainen, M.H.; Gardberg, M.; Kohonen, I.; Lähdesmäki, J., 2013:
Statin-induced myopathy in a patient with previous poliomyelitis

Abd, T.T.; Jacobson, T.A., 2011:
Statin-induced myopathy: a review and update

Hennekens, C.H., 2009:
Statin-induced myopathy: hypothesis about randomized evidence and clinical impressions

Catapano, A.L., 2012:
Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin

Hamann, P.D.H.; Cooper, R.G.; McHugh, N.J.; Chinoy, H., 2014:
Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum"

Cannon, C.S., 2012:
Statin-induced rhabdomyolysis and dermatomyositis: a rare combination

Yildiz, H.; Roelants, V.; Hainaut, P., 2015:
Statin-induced rhabdomyolysis mimicking polymyositis on (18)F-FDG PET imaging

Mendes, P.; Robles, P.Games.; Mathur, S., 2014:
Statin-induced rhabdomyolysis: a comprehensive review of case reports

Komiyama, N., 2009:
Statin-induced structural changes in coronary plaques evaluated by intracoronary imaging

Biondi, E.; Elisa, B., 2008 :
Statin-like drugs for the treatment of brain cholesterol loss in Alzheimer's disease

D.D.nna, L.; D.L.ca, G.; Mazzotti, F.; Napoli, A.; Salerno, R.; Taverna, D.; Sindona, G., 2009:
Statin-like principles of bergamot fruit (Citrus bergamia): isolation of 3-hydroxymethylglutaryl flavonoid glycosides

Ali, F.; Hamdulay, S.S.; Kinderlerer, A.R.; Boyle, J.J.; Lidington, E.A.; Yamaguchi, T.; Soares, M.P.; Haskard, D.O.; Randi, A.M.; Mason, J.C., 2007:
Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1

Kosmas, C.E.; Alkhawam, H.; El-Hunjul, M.; Wagman, G.; Kahn, M.R.; Grady, K.M.; Vittorio, T.J., 2014:
Statin-mediated low-density lipoprotein lowering in chronic congestive heart failure

Matsuura, M.; Suzuki, T.; Suzuki, M.; Tanaka, R.; Ito, E.; Saito, T., 2011:
Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma

McDonagh, J., 2015:
Statin-related cognitive impairment in the real world: you'll live longer, but you might not like it

Marie, I.; Boyer, O., 2014:
Statin-related inflammatory myopathy

Soljanlahti, S.; Raininko, R.; Hyttinen, L.; Lauerma, K.; Keto, P.; Vuorio, A.F.; Autti, T., 2007:
Statin-treated familial hypercholesterolemia patients with coronary heart disease and pronounced atherosclerosis do not have more brain lesions than healthy controls in later middle age

Ghavami, S.; Mutawe, M.M.; Hauff, K.; Stelmack, G.L.; Schaafsma, D.; Sharma, P.; McNeill, K.D.; Hynes, T.S.; Kung, S.K.; Unruh, H.; Klonisch, T.; Hatch, G.M.; Los, M.; Halayko, A.J., 2010:
Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c

Brown, C., 2014:
Statin-use debate creates furor at The BMJ

Kalhan, A.; Rees, A., 2011:
Statin/ezetimibe combination therapy: emerging evidence

Bifulco, M.; Endo, A., 2015:
Statin: new life for an old drug

L.S.hiavo, A.; Brunetti, G.; Puca, R.V.; Sangiuliano, S.; Ruocco, E., 2008:
Statinat-induced pemphigus: over-the-counter drugs too may be harmful!

Parhofer, K., 2009:
Statines for all or individualized lipid lowering therapy?

Kuznetsov, V.V., 2007:
Statines in the system of rehabilitation of patients who had suffered from atherosclerotic ischemic stroke

Volchegorskiĭ, I.A.; Novoselov, P.N.; Dudarova, T.P.; Bolotov, A.A., 2013:
Stating the need of surgical treatment of the infiltrative lung tuberculosis

Ojeda, J.; Mieres, M.; Soto, F.; Arnes, Vónica.; Paredes, E.; Navarrete, Mía., 2018:
Computer tomographic imaging in 4 dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype

DerGurahian, J., 2008:
Stating their wishes. Healthcare IT initiatives gain in prominence among governors' priorities

Han, B.H.; Weinberger, Y.; Sutin, D., 2015:
Statinopause

Skinner, A., 2016:
Statins

Banach, M.; Czuczwar, Sław.J.; Borowicz, K.K., 2015:
Statins - are they anticonvulsant?

Cybulska, B.; Kłosiewicz Latoszek, L., 2012:
Statins 25 years in preventive cardiology

Seo, M.; Inoue, I.; Ikeda, M.; Nakano, T.; Takahashi, S.; Katayama, S.; Komoda, T., 2009:
Statins Activate Human PPARalpha Promoter and Increase PPARalpha mRNA Expression and Activation in HepG2 Cells

Rodriguez, B.; Valdez, H.; Mijch, A.; Watson, K.; Lederman, M.M.; McComsey, G.A.; Loupa, C.V.; Woolley, I., 2007:
Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART

Bloom, H.L.; Shukrullah, I.; Veledar, E.; Gutmann, R.; London, B.; Dudley, S.C., 2010:
Statins Decrease Oxidative Stress and ICD Therapies

Folkeringa, R.J.; Tieleman, R.G.; Maessen, J.G.; Prins, M.H.; Nieuwlaat, R.; Crijns, H.J.G.M., 2011:
Statins Do Not Reduce Atrial Fibrillation After Cardiac Valvular Surgery: A Single Centre Observational Study

Yang, D.; Han, Y.; Zhang, J.; Chopp, M.; Seyfried, D.M., 2013:
Statins Enhance Expression of Growth Factors and Activate the PI3K/Akt-mediated Signaling Pathway after Experimental Intracerebral Hemorrhage

Vinayak, S.; Kurian, A.W., 2009:
Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease

Kojanian, H.; Szafran-Swietlik, A.; Onstead-Haas, L.M.; Haas, M.J.; Mooradian, A.D., 2014 :
Statins Prevent Dextrose-Induced Endoplasmic Reticulum Stress and Oxidative Stress in Endothelial and HepG2 Cells

Yang, D.; Knight, R.A.; Han, Y.; Karki, K.; Zhang, J.; Chopp, M.; Seyfried, D.M., 2013:
Statins Protect the Blood Brain Barrier Acutely after Experimental Intracerebral Hemorrhage

Pich, C.; Teiti, I.; Rochaix, P.; Mariamé, B.; Couderc, B.; Favre, G.; Tilkin-Mariamé, A-Françoise., 2013:
Statins Reduce Melanoma Development and Metastasis through MICA Overexpression

Kuebler, W.M., 2012:
Statins STAT for (over)ventilated patients?

Wada, H.; Abe, M.; Ono, K.; Morimoto, T.; Kawamura, T.; Takaya, T.; Satoh, N.; Fujita, M.; Kita, T.; Shimatsu, A.; Hasegawa, K., 2008:
Statins activate GATA-6 and induce differentiated vascular smooth muscle cells

Herrero-Martin, G.; López-Rivas, A., 2008:
Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins

Wade, J.B., 2011:
Statins affect AQP2 traffic

Terai, N.; Spoerl, E.; Fischer, S.; Hornykewycz, K.; Haustein, M.; Haentzschel, J.; Pillunat, L.E., 2011:
Statins affect ocular microcirculation in patients with hypercholesterolaemia

Hol, J.; Otterdal, K.; Breland, U.M.; Stang, E.; Pedersen, T.M.; Hagelsteen, K.; Ranheim, T.; Kasprzycka, M.; Halvorsen, B.; Haraldsen, G.; Aukrust, Pål., 2013:
Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies

Roth, G.A., 2014:
Statins after acute coronary syndrome: a missed opportunity

Steurer, J., 2013:
Statins after drug discontinuation are usually well tolerated

Goldstein, L.B., 2011:
Statins after intracerebral hemorrhage: to treat or not to treat

Mascitelli, L.; Goldstein, M.R., 2012:
Statins after ischemic stroke of undetermined etiology in young adults

Sicras-Mainar, A.; Planas-Comes, A.; Frias-Garrido, X.; Navarro-Artieda, R.; de Salas-Cansado, M.; Rejas-Gutiérrez, J., 2012:
Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease

Dashti-Khavidaki, S.; Moghaddas, A.; Heydari, B.; Khalili, H.; Lessan-Pezeshki, M.; Lessan-Pezeshki, M., 2014:
Statins against drug-induced nephrotoxicity

Shi, X.Qun.; Lim, T.K.Y.; Lee, S.; Zhao, Y.Qing.; Zhang, J., 2011:
Statins alleviate experimental nerve injury-induced neuropathic pain

Metterlein, T.; Schuster, F.; Tadda, L.; Hager, M.; Roewer, N.; Anetseder, M., 2011:
Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals

Maher, B.M.; Dhonnchu, T.Ni.; Burke, J.P.; Soo, A.; Wood, A.E.; Watson, R.W.G., 2008:
Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?

Szabó, Mónika.; Veres, Z.; Bátai-Konczos, A.; Kékesi, O.; Kis, E.; Szabó, K.; Jemnitz, K., 2015:
Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes

Tousoulis, D.; Antoniades, C.; Stefanadis, C., 2007:
Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?

Van Der Putten, Céline.; Kuipers, H.F.; Zuiderwijk-Sick, E.A.; Van Straalen, L.; Kondova, I.; Van Den Elsen, P.J.; Bajramovic, J.J., 2012:
Statins amplify TLR-induced responses in microglia via inhibition of cholesterol biosynthesis

Beltowski, J., 2010:
Statins and ALS: the possible role of impaired LXR signaling

Asher, J.; Houston, M., 2007:
Statins and C-reactive protein levels

Godlee, F., 2015:
Statins and The BMJ

Golomb, B.Alexandra., 2014:
Statins and activity: proceed with caution

Kor, D.Jon., 2012:
Statins and acute lung injury: Holy Grail or the next to fail?

Lavie, C.J.; Mehra, M.R., 2009:
Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF

Wong, T.Y.; Rogers, S.L., 2007:
Statins and age-related macular degeneration: time for a randomized controlled trial?

Brugts, J.Jan.; Deckers, J.W., 2011:
Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors

Ray, K.K.; Seshasai, S.Rao.Kondapally.; Erqou, S.; Sever, P.; Jukema, J.Wouter.; Ford, I.; Sattar, N., 2010:
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants

Chodick, G.; Shalev, V., 2011:
Statins and all-cause mortality in high-risk primary prevention: a second look at the results

Mehta, J.L., 2010:
Statins and altered glucose metabolism: a laboratory curiosity or a new disease?

Naji, F.; Suran, D.; Kanic, V.; Vokac, D.; Sabovic, M., 2009:
Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion

Sørensen, H.Toft.; Lash, T.L., 2010:
Statins and amyotrophic lateral sclerosis--the level of evidence for an association

Zheng, Z.; Sheng, L.; Shang, H., 2014:
Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis

Pichon, G.; Deflandre, E.; Opsomer, O.; Pichon, L.; Jaucot, J., 2012:
Statins and anesthesia: dilemma or obviousness? Is there still room for withdrawal of chronic statin therapy before surgery?

Bambakidis, N.C.; Selman, W.R., 2012:
Statins and aneurysms

Khaidakov, M.; Wang, W.; Khan, J.A.; Kang, B-Yong.; Hermonat, P.L.; Mehta, J.L., 2009:
Statins and angiogenesis: is it about connections?

Kariya, T.; Harada, K., 2012:
Statins and antidyslipidemic agents

Chapman, J., 2009:
Statins and antiplatelet agents: complementary mechanisms of action at the coronary artery level

Choi, S.Eun.; Perzan, K.E.; Tramontano, A.C.; Kong, C.Yin.; Hur, C., 2015:
Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis

Pawlak, J.; Ziętkowski, Z.; Bodzenta-Łukaszyk, A., 2011:
Statins and asthma

Zeki, A.A., 2015:
Statins and asthma: where we stand, and the next critical steps in research

Koutbi, L.; Roy, D.; Talajic, M.; Blondeau, L.; Franceschi, Fédéric.; Rivard, L.; Macle, L.; Andrade, J.G.; Guerra, P.G.; Thibault, B.; Dubuc, M.; Khairy, P., 2014:
Statins and atrial fibrillation in patients with left ventricular dysfunction: insights from the AF-CHF trial

Savelieva, I.; Camm, A.John., 2011:
Statins and atrial fibrillation: do we need a further study?

Qian, L.; Xu, L.; Lin, Y.; Peng, Y., 2010:
Statins and beta-cell function

Murtola, T.J., 2015:
Statins and biochemical recurrence after radical prostatectomy - who benefits?

Trompet, S.; Jukema, J.Wouter.; Ford, I.; Shepherd, J.; Gussekloo, J.; Buckley, B.M.; Westendorp, R.G.J.; de Craen, A.J.M., 2008:
Statins and blood pressure

Sarafidis, P.A.; Kanaki, A.I.; Lasaridis, A.N., 2007 :
Statins and blood pressure: is there an effect or not?

Yue, J.; Zhang, X.; Dong, B.; Yang, M., 2011:
Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials

Morandi, A.; Hughes, C.G.; Girard, T.D.; McAuley, D.F.; Ely, E.Wesley.; Pandharipande, P.P., 2011:
Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill

Tapia-Perez, H.; Sanchez-Aguilar, M.; Torres-Corzo, J.; Rodriguez-Leyva, I.; Herrera-Gonzalez, L.B., 2007:
Statins and brain protection mechanisms

Eaton, M.; Eklof, J.; Beal, J.R.; Sahmoun, A.E., 2010:
Statins and breast cancer in postmenopausal women without hormone therapy

Ahern, T.P.; Lash, T.L.; Damkier, P.; Christiansen, P.M.; Cronin-Fenton, D.P., 2015:
Statins and breast cancer prognosis: evidence and opportunities

Mannello, F.; Tonti, G.A., 2009:
Statins and breast cancer: may matrix metalloproteinase be the missing link

Anonymous, 2008:
Statins and cancer

Gazzerro, P.; Bifulco, M., 2013:
Statins and cancer in gastroenterology: new insight?

Mascitelli, L.; Pezzetta, F.; Goldstein, M.R., 2009:
Statins and cancer in patients with asthma

Bonovas, S.; Sitaras, N.M., 2009 :
Statins and cancer risk: a confounded association

Goldstein, M.R.; Mascitelli, L.; Pezzetta, F., 2008:
Statins and cancer risk: decrease or increase?

Caporaso, N.E., 2012:
Statins and cancer-related mortality--let's work together

Kuoppala, J.; Lamminpää, A.; Pukkala, E., 2008:
Statins and cancer: A systematic review and meta-analysis

Taylor, M.L.; Wells, B.J.; Smolak, M.J., 2008:
Statins and cancer: a meta-analysis of case-control studies

Thompson, J.S.; Sood, A.; Arora, R., 2010:
Statins and cancer: a potential link?

Garwood, S., 2011:
Statins and cardiac surgery

Ludman, A.; Venugopal, V.; Yellon, D.M.; Hausenloy, D.J., 2009:
Statins and cardioprotection--more than just lipid lowering?

Anonymous, 2014:
Statins and cardiovascular disease

Zhou, Q.; Liao, J.K., 2009:
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy

Athyros, V.G.; Tziomalos, K.; Karagiannis, A.; Mikhailidis, D.P., 2009:
Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention

Athyros, V.G.; Katsiki, N.; Tziomalos, K.; Gossios, T.D.; Theocharidou, E.; Gkaliagkousi, E.; Anagnostis, P.; Pagourelias, E.D.; Karagiannis, A.; Mikhailidis, D.P., 2013:
Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study

Marasini, B.; Massarotti, M., 2012:
Statins and cardiovascular risk in rheumatic diseases

Riccioni, G., 2009:
Statins and carotid intima-media thickness reduction: an up-to-date review

Gaynes, B.I., 2014:
Statins and cataract

Ebinger, M.; Brunecker, P.; Schultze-Amberger, Jörg.; Gertz, K.; Müller, B.; Fiebach, J.B.; Dichgans, M.; Endres, M., 2013:
Statins and cerebral perfusion in patients with leukoaraiosis--a translational proof-of-principal MRI study

Stein, E.A., 2007:
Statins and children: whom do we treat and when?

Lakhan, S.E.; Bagchi, S.; Hofer, M., 2010:
Statins and clinical outcome of acute ischemic stroke: a systematic review

Swiger, K.J.; Manalac, R.J.; Blumenthal, R.S.; Blaha, M.J.; Martin, S.S., 2014:
Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects

Steenland, K.; Zhao, L.; Goldstein, F.C.; Levey, A.I., 2013:
Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment

Sparks, L., 2009 :
Statins and cognitive function

Richardson, K.; Schoen, M.; French, B.; Umscheid, C.A.; Mitchell, M.D.; Arnold, S.E.; Heidenreich, P.A.; Rader, D.J.; deGoma, E.M., 2014:
Statins and cognitive function: a systematic review

Benito-León, Jín.; Louis, E.D.; Vega, S.; Bermejo-Pareja, Félix., 2010:
Statins and cognitive functioning in the elderly: a population-based study

Gracias, G.; Garrison, S.; Allan, G.Michael., 2015:
Statins and cognitive impairment

Martin, J., 2008:
Statins and congestive heart failure

Briguori, C.; Napolitano, G.; Condorelli, G., 2016:
Statins and contrast-induced acute kidney injury

Gandhi, S.; Mosleh, W.; Abdel-Qadir, H.; Farkouh, M.E., 2014:
Statins and contrast-induced acute kidney injury with coronary angiography

Paraskevas, K.I.; Giannoukas, A.D.; Mikhailidis, D.P., 2012:
Statins and contrast-induced nephropathy: issues requiring further investigation

Kulik, A.; Ruel, M., 2009:
Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety

Biasucci, L.M.; Stefanelli, A.; Biasillo, G., 2012:
Statins and coronary artery disease: clinical evidence and future perspective

Celik, T.; Demirkol, S.; Celik, M.; Yuksel, U.Cagdas.; Iyisoy, A., 2012 :
Statins and coronary microvascular dysfunction in patients with acute ST segment elevation myocardial infarction

Golightly, L.K.; Barber, G.R.; Barron, M.A.; Page, R.L., 2013:
Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability

Morandi, A.; Hughes, C.G.; Thompson, J.L.; Pandharipande, P.P.; Shintani, A.K.; Vasilevskis, E.E.; Han, J.H.; Jackson, J.C.; Laskowitz, D.T.; Bernard, G.R.; Ely, E.Wesley.; Girard, T.D., 2016:
Statins and delirium during critical illness: a multicenter, prospective cohort study

Taburyanskaya, M.; Hassig, T., 2015:
Statins and delirium: is there a role?

Ikewaki, K., 2014:
Statins and dementia: does length of statins use matter?

Feeman, W.E., 2008:
Statins and diabetes

Hitman, G.A., 2015:
Statins and diabetes

Anonymous, 2014:
Statins and diabetes risk

Mascitelli, L.; Goldstein, M.R., 2014:
Statins and diabetes: are numbers tortured on JUPITER?

Pritchett, J.W., 2007:
Statins and dietary fish oils improve lipid composition in bone marrow and joints

Bielecka-Dabrowa, A.; Mikhailidis, D.P.; Hannam, S.; Aronow, W.S.; Rysz, J.; Banach, M., 2011:
Statins and dilated cardiomyopathy: do we have enough data?

Onusko, E., 2008:
Statins and elevated liver tests: what's the fuss?

Filip-Ciubotaru, F-Mihaela.; Manciuc, C.; Foia, L., 2010:
Statins and endothelial dysfunction

L.V.gnera, S.; Condorelli, R.A.; Vicari, E.; Calogero, A.E., 2012:
Statins and erectile dysfunction: a critical summary of current evidence

Do, C.; Huyghe, E.; Lapeyre-Mestre, M.; Montastruc, J.Louis.; Bagheri, H., 2009:
Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database

Davignon, J.; Dubuc, Gève., 2009:
Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels

Neil, A.; Humphries, S.E., 2009:
Statins and familial hypercholesterolaemia

Pierno, S.; Camerino, G.M.; Cippone, V.; Rolland, J-F.; Desaphy, J-F.; D.L.ca, A.; Liantonio, A.; Bianco, G.; Kunic, J.D.; George, A.L.; Conte Camerino, D., 2010:
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression

Zdebik, A.A., 2010:
Statins and fibrate target ClC-1 - from side effects to CLC pharmacology

Wei, W.; Clockaerts, S.; Bastiaansen-Jenniskens, Y.M.; Gierman, L.M.; Botter, S.M.; Bierma-Zeinstra, S.M.A.; Weinans, H.; Verhaar, J.A.N.; Kloppenburg, M.; Zuurmond, A-M.; van Osch, G.J.V.M., 2014:
Statins and fibrates do not affect development of spontaneous cartilage damage in STR/Ort mice

Shimoyama, S., 2011:
Statins and gastric cancer risk

Sági, V.; Herszényi, László.; Tulassay, Z.; Gasztonyi, Báta., 2014:
Statins and gastrointestinal cancers

Tsuda, K., 2009:
Statins and gender-related difference in endothelial function in cerebral small vessel disease

Erqou, S.; Lee, C.Christine.; Adler, A.I., 2015:
Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis

Hitman, G.A., 2012:
Statins and glycaemic control--a cause for concern?

Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P., 2010:
Statins and heart failure

Rzouq, F.; Alahdab, F.; Olyaee, M., 2015:
Statins and hepatitis C virus infection: an old therapy with new scope

Emanuele, E., 2010:
Statins and hepatitis C virus: friend or foe?

Goldstein, M.R.; Mascitelli, L.; Pezzetta, F., 2009:
Statins and hepatitis C virus: more caution and less enthusiasm

Helin-Salmivaara, A.; Korhonen, M.J.; Lehenkari, P.; Junnila, S.Y.T.; Neuvonen, P.J.; Ruokoniemi, Päivi.; Huupponen, R., 2014:
Statins and hip fracture prevention--a population based cohort study in women

Cífková, R.; Nilsson, P.M., 2009:
Statins and hypertension

Quist-Paulsen, P., 2011:
Statins and inflammation: an update

Shantsila, E.; Watson, T.; Lip, G.Y.H., 2008:
Statins and inflammation: reciprocal effectors to endothelial progenitors?

Grijalva, C.G.; Arbogast, P.G.; Griffin, M.R., 2007:
Statins and influenza/COPD mortality

Walsh, E.E., 2012:
Statins and influenza: can we move forward?

Fernández, A.B.; Karas, R.H.; Alsheikh-Ali, A.A.; Thompson, P.D., 2008:
Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports

Zheng, H.; Hu, Z.; Lu, W., 2015:
Statins and intracerebral hemorrhage

Hackam, D.G.; Austin, P.C.; Huang, A.; Juurlink, D.N.; Mamdani, M.M.; Paterson, J.Michael.; Hachinski, V.; Li, P.; Kapral, M.K., 2012:
Statins and intracerebral hemorrhage: a retrospective cohort study

Abdul Rahman, M.N.A.; Chetter, I.C., 2011:
Statins and ischaemia reperfusion injury: a molecular biological review

Spence, J.David., 2014:
Statins and ischemic stroke

Goldstein, L.B., 2009:
Statins and ischemic stroke severity: cytoprotection

Campion, J.; Western, A., 2008:
Statins and joint pain

Bigazzi, R.; Grimaldi, D.; Bianchi, S., 2013:
Statins and kidney disease

Jenkins, M.; Goldsmith, D., 2012:
Statins and kidney disease: is the study of heart and renal protection at the cutting edge of evidence?

Lamon-Fava, S., 2014:
Statins and lipid metabolism: an update

Heimbürger, O., 2012:
Statins and lipid-lowering strategies in PD

Bianchi, S.; Grimaldi, D.; Bigazzi, R., 2011:
Statins and lipid-lowering strategies in cardiorenal patients

Thapar, M.; Russo, M.W.; Bonkovsky, H.L., 2014:
Statins and liver injury

Pullan, M.; Chalmers, J.; Mediratta, N.; Shaw, M.; McShane, J.; Poullis, M., 2014:
Statins and long-term survival after isolated valve surgery: the importance of valve type, position and procedure

Gray, J.; Alberts, W.Michael.; Bepler, G., 2007:
Statins and lung cancer risk

Cohen, P.G., 2011:
Statins and male hypogonadism

Davis, R.; Reveles, K.R.; Ali, S.K.; Mortensen, E.M.; Frei, C.R.; Mansi, I., 2015:
Statins and male sexual health: a retrospective cohort analysis

Mascitelli, L.; Pezzetta, F., 2007:
Statins and medicalization of lifestyle issues

Sviridov, D.; Nestel, P.; Watts, G., 2007:
Statins and metabolism of high density lipoprotein

Golomb, B.A.; Kopersk, S.; Evans, M.A., 2010:
Statins and muscle adverse effects: a complementary perspective

Yosef, Y.; Schurr, D.; Constantini, N., 2014:
Statins and muscle pain

Brosteaux, C.; Ruiz, J.; Buclin, T.; Kuntzer, T.; Rodondi, N., 2010:
Statins and muscular side-effects

Baudrand, R.; Williams, G.H., 2014:
Statins and musculoskeletal adverse events

Mansi, I.; Frei, C.R.; Pugh, M.Jo.; Makris, U.; Mortensen, E.M., 2013:
Statins and musculoskeletal conditions, arthropathies, and injuries

Hoffmeister, E., 2013:
Statins and musculoskeletal pain

Porter, K.E.; Turner, N.A., 2011:
Statins and myocardial remodelling: cell and molecular pathways

Fonarow, G.C., 2008:
Statins and n-3 fatty acid supplementation in heart failure

Mascitelli, L.; Pezzetta, F.; Goldstein, M.R., 2008:
Statins and natural regulatory T cells in HIV infection

Turpin-Fenoll, L.; Millan-Pascual, J.; Martin-Estefania, C., 2008:
Statins and neuromuscular pathology

Wood, W.Gibson.; Eckert, G.P.; Igbavboa, U.; Müller, W.E., 2010:
Statins and neuroprotection: a prescription to move the field forward

Wood, W.Gibson.; Mΰller, W.E.; Eckert, G.P., 2015:
Statins and neuroprotection: basic pharmacology needed

Barylski, M.; Nikolic, D.; Banach, M.; Toth, P.P.; Montalto, G.; Rizzo, M., 2015:
Statins and new-onset diabetes

Seymour, K.; Stein, J.; Han, X.; Maier, K.G.; Gahtan, V., 2015:
Statins and nitric oxide donors affect thrombospondin 1-induced chemotaxis

Tsuda, K., 2008:
Statins and nitric oxide production against ischemic stroke

Athyros, V.G.; Katsiki, N.; Karagiannis, A.; Mikhailidis, D.P., 2014:
Statins and nonalcoholic fatty liver disease: a bright future?

Poldermans, D., 2011:
Statins and noncardiac surgery: current evidence and practical considerations

Paraskevas, K.I.; Wierzbicki, A.S.; Mikhailidis, D.P., 2012:
Statins and noncardiac vascular disease

Pacheco-Pantoja, E.Leonor.; Alvarez-Nemegyei, J., 2016:
Statins and osteoporosis: a latent promise

Leung, S.; Pokharel, R.; Gong, M.N., 2012:
Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis

Filip-Ciubotaru, F.; Foia, L.; Manciuc, C., 2011:
Statins and oxidative stress

Bradley, M.C.; Hughes, C.M.; Cantwell, M.M.; Murray, L.J., 2011:
Statins and pancreatic cancer risk: a nested case-control study

Norata, G.Danilo.; Catapano, A.Luigi., 2015:
Statins and periodontal inflammation: a pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?

Hudorović, N., 2008:
Statins and perioperative management of patients undergoing cardiovascular surgery

Markel, A., 2016:
Statins and peripheral arterial disease

Coppola, G.; Novo, S., 2007:
Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events

Tan, K.Mun.; Kelly, J.G.; McGarry, K., 2007:
Statins and phenytoin interact - a case history

Lee, D.S.H.; Markwardt, S.; Goeres, L.; Lee, C.G.; Eckstrom, E.; Williams, C.; Fu, R.; Orwoll, E.; Cawthon, P.M.; Stefanick, M.L.; Mackey, D.; Bauer, D.C.; Nielson, C.M., 2014:
Statins and physical activity in older men: the osteoporotic fractures in men study

Chopra, V.; Flanders, S.A., 2011:
Statins and pneumonia

Ewing, I.; White, W., 2011:
Statins and pneumonia. Beware statins with macrolides

Bergström, H.; Andersson, P., 2008:
Statins and polyneuropathy

Ramírez, G.; Briceño, J.; Rojas, A., 2013:
Statins and portal hypertension: a new pharmacological challenge

Carmo, G.A.L.; Calderaro, D.; Marques, Aé.C.; Yu, P.C.; Gualandro, D.M.; Caramelli, B., 2013:
Statins and postoperative atrial fibrillation: a long way ahead

Marcantonio, E.R., 2008:
Statins and postoperative delirium

Shokouhi, S.; Alavi Darazam, I.; Sharifi, G.; Gachkar, L.; Amirsardari, A.; Samadian, M., 2014:
Statins and postoperative infections: a randomized clinical trial

Schouten, O.; Welten, G.M.J.M.; Poldermans, D., 2010:
Statins and postoperative renal function

Lecarpentier, E.; Morel, O.; Fournier, T.; Elefant, E.; Chavatte-Palmer, P.; Tsatsaris, V., 2012:
Statins and pregnancy: between supposed risks and theoretical benefits

Liu, T.; Li, G.; Korantzopoulos, P.; Goudevenos, J.A., 2008:
Statins and prevention of atrial fibrillation in patients with heart failure

van den Hoek, H.L.; Bos, W.Jan.W.; de Boer, A.; van de Garde, E.M.W., 2012:
Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials

Uemura, S., 2014:
Statins and prevention of stent-related late adverse events

Pradelli, D.; Soranna, D.; Scotti, L.; Zambon, A.; Catapano, A.; Mancia, G.; L.V.cchia, C.; Corrao, G., 2013:
Statins and primary liver cancer: a meta-analysis of observational studies

Donner-Banzhoff, N.; Sönnichsen, A., 2008:
Statins and primary prevention of cardiovascular events

Rashid, S.; Francis, G.A., 2008:
Statins and primary prevention: is all the evidence in?

Shantsila, A.; Lip, G.Y.H., 2011:
Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis

Anonymous, 2009:
Statins and prostate cancer

Papadopoulos, G.; Delakas, D.; Nakopoulou, L.; Kassimatis, T., 2011:
Statins and prostate cancer: molecular and clinical aspects

Roy, M.; Kung, H-Jien.; Ghosh, P.M., 2011:
Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins

Garcia-Ruiz, C.; Morales, A.; Fernandez-Checa, J.C., 2012:
Statins and protein prenylation in cancer cell biology and therapy

Bonovas, S.; Nikolopoulos, G.; Sitaras, N.M., 2014:
Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis C virus infection: further evidence is warranted

Athyros, V.G.; Kakafika, A.; Karagiannis, A.; Mikhailidis, D.P., 2007:
Statins and regression of coronary atherosclerosis

Deshmukh, A.; Mehta, J.L., 2011:
Statins and renal disease: friend or foe?

Lee, H-Young.; Sakuma, I.; Ihm, S-Hyun.; Goh, C-Won.; Koh, K.Kon., 2015:
Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease

Hackam, D.G.; Wu, F.; Li, P.; Austin, P.C.; Tobe, S.W.; Mamdani, M.M.; Garg, A.X., 2011:
Statins and renovascular disease in the elderly: a population-based cohort study

Granger Vallée, A.; Canaud, B., 2011:
Statins and resistance to erythropoiesis-stimulating agents: are the two associated?

Marelli, C.; Gunnarsson, C.; Ross, S.; Haas, S.; Stroup, D.F.; Cload, P.; Clopton, P.; DeMaria, A.N., 2011:
Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans

Danaei, G.; García Rodríguez, L.A.; Fernandez Cantero, O.; Hernán, M.A., 2013:
Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival

Lubsen, J., 2010:
Statins and risk of incident diabetes

McEvoy, J.W., 2010:
Statins and risk of incident diabetes

Sattar, N.; Preiss, D.; Murray, H.M.; Welsh, P.; Buckley, B.M.; de Craen, A.J.M.; Seshasai, S.Rao.Kondapally.; McMurray, J.J.; Freeman, D.J.; Jukema, J.Wouter.; Macfarlane, P.W.; Packard, C.J.; Stott, D.J.; Westendorp, R.G.; Shepherd, J.; Davis, B.R.; Pressel, S.L.; Marchioli, R.; Marfisi, R.Maria.; Maggioni, A.P.; Tavazzi, L.; Tognoni, G.; Kjekshus, J.; Pedersen, T.R.; Cook, T.J.; Gotto, A.M.; Clearfield, M.B.; Downs, J.R.; Nakamura, H.; Ohashi, Y.; Mizuno, K.; Ray, K.K.; Ford, I., 2010:
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Shah, R.V.; Goldfine, A.B., 2013:
Statins and risk of new-onset diabetes mellitus

Navarese, E.Pio.; Szczesniak, A.; Kolodziejczak, M.; Gorny, B.; Kubica, J.; Suryapranata, H., 2014:
Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?

Singh, P.Paul.; Singh, S., 2012:
Statins and risk reduction in hepatocellular carcinoma: fact or fiction?

Kohli, P.; Cannon, C.P., 2011:
Statins and safety: can we finally be reassured?

Squizzato, A.; Dentali, F.; Romualdi, E.; Ageno, W., 2008:
Statins and secondary prevention of ischemic and hemorrhagic stroke

McNeish, A.J.; Jimenez-Altayo, F.; Cottrell, G.S.; Garland, C.J., 2013:
Statins and selective inhibition of Rho kinase protect small conductance calcium-activated potassium channel function (K(Ca)2.3) in cerebral arteries

Gao, F.; Linhartova, L.; Johnston, A.McD.; Thickett, D.R., 2008:
Statins and sepsis

Eurich, D.T.; Majumdar, S.R., 2012:
Statins and sepsis - scientifically interesting but clinically inconsequential

Somma, M.M.; Weinstock, P.J., 2011:
Statins and sepsis: a magic bullet or just shooting blanks?

Monneret, G.; Venet, F., 2007:
Statins and sepsis: do we really need to further decrease monocyte HLA-DR expression to treat septic patients?

Woerndle, R.H.; Maxwell, D.L., 2008:
Statins and sepsis: good bullet, disappearing target

O'Kane, C.M.; Perkins, G.D.; McAuley, D.F., 2013:
Statins and sepsis: potential benefit but more unanswered questions

Norata, G.Danilo.; Tibolla, G.; Catapano, A.Luigi., 2015:
Statins and skeletal muscles toxicity: from clinical trials to everyday practice

Joles, J.A., 2007:
Statins and small GTPases: Koch's postulates and chronic kidney disease

Young, R.P.; Hopkins, R.J., 2013:
Statins and small airways disease in COPD

Braunersreuther, V.; Mach, Fçois.; Montecucco, F., 2012:
Statins and stent thrombosis

Rodríguez-Yáñez, M.; Agulla, Jús.; Rodríguez-González, R.; Sobrino, Tás.; Castillo, Jé., 2009:
Statins and stroke

Paciaroni, M.; Hennerici, M.; Agnelli, G.; Bogousslavsky, J., 2007:
Statins and stroke prevention

Paciaroni, M.; Bogousslavsky, J., 2010:
Statins and stroke prevention

Fonseca, F.A.H.; França, C.N.; Póvoa, R.M.S.; Izar, M.Cristina.O., 2010:
Statins and stroke: potential mechanisms for neurovascular protection

Prinz, V.; Endres, M., 2011:
Statins and stroke: prevention and beyond

Bajwa, S.Jit.Singh., 2013:
Statins and succinylcholine interaction: A cause of concern for serious muscular damage in anesthesiology practice!

Tiwari, A., 2007:
Statins and telomere length: risk assessment and management for coronary heart disease

Millar, P.J.; Floras, J.S., 2014:
Statins and the autonomic nervous system

Perna, M.; Baker, M.; Byrne, T.Karl.; Morgan, K., 2011:
Statins and the bariatric patient: characterization and perioperative effects of statin therapy in the gastric bypass patient

Baron, J.A., 2010:
Statins and the colorectum: hope for chemoprevention?

Orsola, A.; Cecchini, Lís.; Bellmunt, J., 2007:
Statins and the effect of BCG on bladder cancer

Schiattarella, G.Giacomo.; Perrino, C.; Magliulo, F.; Ilardi, F.; Serino, F.; Trimarco, V.; Izzo, R.; Amato, B.; Terranova, C.; Cardin, F.; Militello, C.; Leosco, D.; Trimarco, B.; Esposito, G., 2013:
Statins and the elderly: recent evidence and current indications

Kjellevand, T.Ole., 2009:
Statins and the industry

Lazzerini, P.Enea.; Capecchi, P.Leopoldo.; Selvi, E.; Lorenzini, S.; Bisogno, S.; Baldari, C.Tatiana.; Galeazzi, M.; Laghi-Pasini, F., 2011:
Statins and the joint: multiple targets for a global protection?

Udwadia, Z.F.; Dagaonkar, R.S., 2011:
Statins and the lung: hope or hype?

Morley, J.E.; Mahon, G., 2014:
Statins and the nursing home

Bronheim, D., 2007:
Statins and the perioperative period

Taylor, D.G., 2013:
Statins and the quality and outcomes framework

Beri, A.; Contractor, T.; Khasnis, A.; Thakur, R., 2010:
Statins and the reduction of sudden cardiac death: antiarrhythmic or anti-ischemic effect?

Becker, C.; Meier, C.R., 2010:
Statins and the risk of Parkinson disease: an update on the controversy

Bonovas, S.; Filioussi, K.; Flordellis, C.S.; Sitaras, N.M., 2007:
Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients

Lytras, T.; Nikolopoulos, G.; Bonovas, S., 2015:
Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies

Simonyi, Gábor., 2014:
Statins and the risk of diabetes

Corrao, G.; Ibrahim, B.; Nicotra, F.; Soranna, D.; Merlino, L.; Catapano, A.L.; Tragni, E.; Casula, M.; Grassi, G.; Mancia, G., 2015:
Statins and the risk of diabetes: evidence from a large population-based cohort study

Katsiki, N.; Banach, M., 2012:
Statins and the risk of diabetes: the debate

Lee, J.; Lee, S.Hyeon.; Hur, K.Yeon.; Woo, S.Young.; Kim, S.Woo.; Kang, W.Ki., 2013:
Statins and the risk of gastric cancer in diabetes patients

Antoniou, T.; Zheng, H.; Singh, S.; Juurlink, D.N.; Mamdani, M.M.; Gomes, T., 2014:
Statins and the risk of herpes zoster: a population-based cohort study

Chen, G-Lin.; Hsiao, F-Yuan.; Dong, Y-Hui.; Shen, L-Jiuan.; Wu, F-Lin.Lin., 2015:
Statins and the risk of liver injury: a population-based case-control study

Tan, M.; Song, X.; Zhang, G.; Peng, A.; Li, X.; Li, M.; Liu, Y.; Wang, C., 2013:
Statins and the risk of lung cancer: a meta-analysis

Preiss, D.; Sattar, N., 2012:
Statins and the risk of new-onset diabetes: a review of recent evidence

Getzenberg, R.H., 2010:
Statins and the risk of prostate cancer or benign prostatic hyperplasia: biological plausibility

Macedo, A.Filipa.; Douglas, I.; Smeeth, L.; Forbes, H.; Ebrahim, S., 2015:
Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink

Makihara, N.; Kamouchi, M.; Hata, J.; Matsuo, R.; Ago, T.; Kuroda, J.; Kuwashiro, T.; Sugimori, H.; Kitazono, T., 2014:
Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry

Kojro, E.; Füger, P.; Prinzen, C.; Kanarek, A.Maria.; Rat, D.; Endres, K.; Fahrenholz, F.; Postina, R., 2010:
Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis

Buslovich, S.; Salbu, R.; Ramaswamy, R., 2014:
Statins and the trajectory of cognitive decline

Terrosu, P., 2012:
Statins and the "Cabala": the new Note 13

Beattie, W.Scott.; Wijeysundera, D.N., 2010:
Statins and the "healthy user bias" in cardiac surgery

Ho, C.K.M.; Walker, S.W., 2012:
Statins and their interactions with other lipid-modifying medications: safety issues in the elderly

Galus, R.; Zandecki, Łukasz.; Jóźwiak, Jław.; Włodarski, K., 2008:
Statins and their pleiotropic effects

Etienne, D.; Reda, Y., 2014:
Statins and their role in acute pancreatitis: Case report and literature review

Melfi, R.; Nusca, A.; Patti, G.; D.S.iascio, G., 2011:
Statins and their role in pre-percutaneous coronary intervention

Sillesen, H., 2009:
Statins and their use in preventing carotid disease

Palomäki, A., 2012:
Statins and thrombogenesis

Sheng, X.; Wei, L.; Murphy, M.J.; MacDonald, T.M., 2009:
Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study

Frayling, T.M., 2015:
Statins and type 2 diabetes: genetic studies on target

Giannopoulos, S.; Katsanos, A.H.; Kosmidou, M.; Tsivgoulis, G., 2015:
Statins and vascular dementia: a review

Wang, C.; Lerner, R.G.; Frishman, W.H., 2014:
Statins and venous thromboembolic disease prophylaxis

Paraskevas, K.I.; Bessias, N.; Perdikides, T.P.; Mikhailidis, D.P., 2009:
Statins and venous thromboembolism: a novel effect of statins?

Paraskevas, K.I.; Nicolaides, A.N.; Mikhailidis, D.P., 2013:
Statins and venous thromboembolism: the jury is still out

Rosendaal, F.R., 2013:
Statins and venous thrombosis: a story too good to be true?

Aloia, J.F.; Li-Ng, M.; Pollack, S., 2007:
Statins and vitamin D

Iannessi, A.; Beaumont, H.; Hebert, C.; Dittlot, C.; Falewee, M.Noëlle., 2018:
Computer tomography-based body surface area evaluation for drug dosage: Quantitative radiology versus anthropomorphic evaluation

Yavuz, B.; Ertugrul, D.Taner., 2012:
Statins and vitamin D: A hot topic that will be discussed for a long time

Neves, P.L.; Malho, A.; Cabrita, A.; Pinho, A.; Baptista, A.; Morgado, E.; Faísca, Mília.; Carrasqueira, Hínio.; Silva, A.P., 2010:
Statins and vitamin D: a friendly association in pre-dialysis patients

Redberg, R.F., 2014:
Statins and weight gain

Adams, A.E.; Bobrove, A.M.; Gilliam, A.C., 2010:
Statins and "chameleon-like" cutaneous eruptions: simvastatin-induced acral cutaneous vesiculobullous and pustular eruption in a 70-year-old man

Sheen, C.; Vincent, T.; Barrett, D.; Horwitz, E.M.; Hulitt, J.; Strong, E.; Grupp, S.A.; Teachey, D.T., 2012:
Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis

Haag, M.D.M.; Hofman, A.; Koudstaal, P.J.; Stricker, B.H.C.; Breteler, M.M.B., 2008:
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study

Nichols, R.; Hopman, W.M.; Morton, A.R.; Harman, G.J.; Holden, R.M., 2008:
Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients

El-Serag, H.B.; Johnson, M.L.; Hachem, C.; Morgana, R.O., 2009:
Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

Diehm, N.; Becker, G.; Katzen, B.; Benenati, J.; Kovacs, M.; Dick, F., 2008:
Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis

Sierra-Marcos, A.; Alvarez, V.; Faouzi, M.; Burnand, B.; Rossetti, A.O., 2015:
Statins are associated with decreased mortality risk after status epilepticus

Hsu, J.; Andes, D.R.; Knasinski, V.; Pirsch, J.; Safdar, N., 2010:
Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients

Lötsch, F.; Königsbrügge, O.; Posch, F.; Zielinski, C.; Pabinger, I.; Ay, C., 2015:
Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study

Squizzato, A.; Guasti, L.; Ageno, W., 2013:
Statins are better than fibrates in patients with a previous venous thromboembolism

Sattar, N.; Taskinen, M-Riitta., 2012:
Statins are diabetogenic--myth or reality?

Shimoyama, S., 2011:
Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers

Kaess, B.M.; Vasan, R.S., 2011 :
Statins are not associated with a decrease in all cause mortality in a high-risk primary prevention setting

Bonovas, S.; Filioussi, K.; Sitaras, N.M., 2008:
Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies

Alqahtani, S.A.; Sanchez, W., 2008:
Statins are safe for the treatment of hypercholesterolemia in patients with chronic liver disease

Westermann, L.; Spemes, C.; Eysel, P.; Simons, M.; Scheyerer, M.J.; Siewe, J.; Baschera, D., 2018:
Computer tomography-based morphometric analysis of the cervical spine pedicles C3-C7

Singla, S.; Jacobson, J.R., 2013:
Statins as a novel therapeutic strategy in acute lung injury

John, S.G.; Thorn, J.; Sobonya, R., 2015:
Statins as a potential risk factor for autoimmune diseases: a case report and review

Elkind, M.S.V., 2008:
Statins as acute-stroke treatment

Young, R.P.; Hopkins, R.J.; Agusti, A., 2014:
Statins as adjunct therapy in COPD: how do we cope after STATCOPE?

Liao, J.; Farmer, J.A., 2010:
Statins as adjunctive therapy in the management of hypertension

Abuissa, H.; O'Keefe, J.H.; Bybee, K.A., 2010:
Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias

Antonopoulos, A.S.; Margaritis, M.; Lee, R.; Channon, K.; Antoniades, C., 2012:
Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials

Carr, A., 2011:
Statins as anti-inflammatory therapy in HIV disease?

Abuissa, H.; O'Keefe, J.H.; Bybee, K.A., 2010:
Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation

Feldstein, C.A., 2008:
Statins as antihypertensives

Violi, F.; Calvieri, C.; Ferro, D.; Pignatelli, P., 2013:
Statins as antithrombotic drugs

Brittain, S.B.; Gohil, S.V.; Nair, L.S., 2015:
Statins as bioactive molecules to support bone regeneration

Walsh, G.M., 2008:
Statins as emerging treatments for asthma and chronic obstructive pulmonary disease

Ostadal, P., 2012:
Statins as first-line therapy for acute coronary syndrome?

Bergman, M.; Salman, H.; Djaldetti, M.; Bessler, H., 2011:
Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC

Forero-Peña, D.A.; Gutierrez, F.R.S., 2014:
Statins as modulators of regulatory T-cell biology

Bhardwaj, A., 2012:
Statins as neuroprotectants after subarachnoid hemorrhage

Sierra, S.; Ramos, M.C.; Molina, P.; Esteo, C.; Vázquez, J.Antonio.; Burgos, J.S., 2011:
Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death

Fallahzadeh, M.K.; Namazi, M.R.; Vakili, H.; Soveid, M., 2010:
Statins as potential addition to anti-Graves' ophthalmopathy armamentarium

Wong, R.P.M.; Davis, T.M.E., 2009:
Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs

Ahmed, M.H.; Hamad, M.A.; Routh, C.; Connolly, V., 2012:
Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions

Violi, F.; Pignatelli, P., 2014:
Statins as regulators of redox signaling in platelets

Margaritis, M.; Channon, K.M.; Antoniades, C., 2014:
Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering

Yang, J.; Huang, C.; Yang, J.; Jiang, H.; Ding, J., 2011:
Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway

Miyata, R.; Hiraiwa, K.; Cheng, J.Chih.; Bai, N.; Vincent, R.; Francis, G.A.; Sin, D.D.; Van Eeden, S.F., 2013:
Statins attenuate the development of atherosclerosis and endothelial dysfunction induced by exposure to urban particulate matter (PM10)

Kodach, L.L.; Jacobs, R.J.; Voorneveld, P.W.; Wildenberg, M.E.; Verspaget, H.W.; van Wezel, T.; Morreau, H.; Hommes, D.W.; Peppelenbosch, M.P.; van den Brink, G.R.; Hardwick, J.C.H., 2012:
Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway

Stalenhoef, A.F.H., 2007:
Statins available from chemist shops will not positively affect health

Thomas, S., 2007:
Statins available from chemist shops will positively affect health

Eagle, K.A.; Chopra, V., 2010:
Statins before coronary procedures a new indication for an old friend

Frey, P.; Waters, D.D., 2011:
Statins before stents: does an ounce of prevention improve outcomes?

Anonymous, 2010:
Statins before vascular surgery

Benton, J.A.; Kern, H.B.; Leinwand, L.A.; Mariner, P.D.; Anseth, K.S., 2010:
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression

Macchia, A.; Laffaye, Nás.; Comignani, P.D.; Cornejo Pucci, E.; Igarzabal, C.; Scazziota, A.S.; Herrera, L.; Mariani, J.A.; Bragagnolo, J.C.; Catalano, H.; Tognoni, G.; Nicolucci, A., 2012:
Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial

Chan, S.Y.; Mancini, G.B.John.; Ignaszewski, A.; Frohlich, J., 2008:
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study

Chana, R.S.; Sidaway, J.E.; Brunskill, N.J., 2008:
Statins but not thiazolidinediones attenuate albumin-mediated chemokine production by proximal tubular cells independently of endocytosis

Zeeh, J., 2013:
Statins can damage muscles and joints

Gale, J.; Danesh-Meyer, H.V., 2014:
Statins can induce myasthenia gravis

Toft-Petersen, A.Pernille.; Thomsen, R.Wernich.; Schmidt, E.Berg.; Larsen, T.Bjerregaard., 2011:
Statins can maybe reduce the risk of venous thromboembolism

Jakobisiak, M.; Golab, J., 2010:
Statins can modulate effectiveness of antitumor therapeutic modalities

Berner, J.E., 2010:
Statins can produce ataxia in bipolar disorder: two case reports

Garnett, D.John.; Greenhough, T.James., 2013:
Statins cause profound effects on gene expression in human cancer cells in vitro: the role of membrane microdomains

Toyama, K.; Sugiyama, S.; Oka, H.; Iwasaki, Y.; Sumida, H.; Tanaka, T.; Tayama, S.; Jinnouchi, H.; Ogawa, H., 2015:
Statins combined with exercise are associated with the increased renal function mediated by high-molecular-weight adiponectin in coronary artery disease patients

Sipkoff, M., 2008:
Statins continue to be ubiquitous, but increasingly controversial

Dje N'Guessan, P.; Riediger, F.; Vardarova, K.; Scharf, S.; Eitel, J.; Opitz, B.; Slevogt, H.; Weichert, W.; Hocke, A.C.; Schmeck, B.; Suttorp, N.; Hippenstiel, S., 2009 :
Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells

Kreklau, A.; Lopez Benitez, R.; Fornaro, Jürgen.; Meili, G.; Günthert, A., 2018:
Computer Tomography-Guided Percutaneous Indocyanine Green Injection for Intraoperative Mapping of Metastatic Suspected Lesions

Gan, H-Li.; Zhang, J-Qun.; Bo, P.; Wang, S-Xun.; Lu, C-Shang., 2010:
Statins decrease adverse outcomes in coronary artery bypass for extensive coronary artery disease as well as left main coronary stenosis

Barylski, M.; Nikfar, S.; Mikhailidis, D.P.; Toth, P.P.; Salari, P.; Ray, K.K.; Pencina, M.J.; Rizzo, M.; Rysz, J.; Abdollahi, M.; Nicholls, S.J.; Banach, M., 2013:
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants

Jin, Y.; Tachibana, I.; Takeda, Y.; He, P.; Kang, S.; Suzuki, M.; Kuhara, H.; Tetsumoto, S.; Tsujino, K.; Minami, T.; Iwasaki, T.; Nakanishi, K.; Kohmo, S.; Hirata, H.; Takahashi, R.; Inoue, K.; Nagatomo, I.; Kida, H.; Kijima, T.; Ito, M.; Saya, H.; Kumanogoh, A., 2014:
Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages

Sivri, N.; Tekin, G.; Yalta, K.; Aksoy, Y.; Senen, K.; Yetkin, E., 2014:
Statins decrease mean platelet volume irrespective of cholesterol lowering effect

Ajrouche, R.; Al-Hajje, A.; El-Helou, N.; Awada, S.; Rachidi, S.; Zein, S.; Salameh, P., 2013:
Statins decrease mortality in Lebanese patients with sepsis: A multicenter study

Reis, P.A.; Estato, V.; da Silva, T.I.; d'Avila, J.C.; Siqueira, L.D.; Assis, E.F.; Bozza, P.T.; Bozza, F.A.; Tibiriça, E.V.; Zimmerman, G.A.; Castro-Faria-Neto, H.C., 2013:
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria

Khemasuwan, D.; Divietro, M.L.; Tangdhanakanond, K.; Pomerantz, S.C.; Eiger, G., 2010:
Statins decrease the occurrence of venous thromboembolism in patients with cancer

Tripodi, A.; Pellegatta, F.; Chantarangkul, V.; Grigore, L.; Garlaschelli, K.; Baragetti, A.; Lemma, L.; Catapano, A., 2015:
Statins decrease thrombin generation in patients with hypercholesterolemia

Ponroy, N.; Taveira, A.; Mueller, N.J.; Millard, A-Laure., 2015:
Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains

Kwatra, S.G., 2011:
Statins differ significantly in their anti-inflammatory activity

Hinerfeld, D.A.; Moonis, M.; Swearer, J.M.; Baker, S.P.; Caselli, R.J.; Rogaeva, E.; St George-Hyslop, P.; Pollen, D.A., 2007:
Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects

Puccetti, L.; Pasqui, A.Laura.; Scarpini, F.; Cappellone, R.; Ghezzi, A.; Ceccatelli, L.; Auteri, A., 2012:
Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments

Nabatov, A.A.; Pollakis, G.; Linnemann, T.; Paxton, W.A.; de Baar, M.P., 2007:
Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1

Feeman, W.E., 2014:
Statins do lower cardiovascular mortality

Ashman, N.; Banerjee, A.; Yaqoob, M.M., 2009:
Statins do not affect mineral metabolism in chronic kidney disease: a retrospective analysis

Robinson, C.; Alfonso, H.; Woo, S.; Walsh, A.; Olsen, N.; Musk, A.W.; Robinson, B.W.S.; Nowak, A.K.; Lake, R.A., 2015:
Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans

Spence, J.David., 2012:
Statins do not cause intracerebral hemorrhage

Choi, C.Ung.; Seo, H.Seog.; Lee, E.Mi.; Shin, S.Yong.; Choi, U-Jung.; Na, J.Oh.; Lim, H.Euy.; Kim, J.Won.; Kim, E.Ju.; Rha, S-Woon.; Park, C.Gyu.; Oh, D.Joo., 2011:
Statins do not decrease small, dense low-density lipoprotein

Kaiserman, N.; Vinker, S.; Kaiserman, I., 2009:
Statins do not decrease the risk for wet age-related macular degeneration